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Description
[0001] The present invention relates to nucleic acid derived from Perkinsus marinus which encodes a 9-elongase,
∆8-desaturase and a ∆5-desaturase enzyme. All of the coding sequences can be transcribed as a single transcript,
which simplifies the process of transforming cells required to express all three proteins. The invention also relates to the
individual coding sequences and to proteins encoded by these sequences as well as to a process for converting linoleic
acid to arachidonic acid.
[0002] Fatty acids and triacylglycerides have a multiplicity of applications in the food industry, in animal nutrition, in
cosmetics and in the pharmacological sector. Depending on whether they are free saturated or unsaturated fatty acids
or else triacylglycerides with an elevated content of saturated or unsaturated fatty acids, they are suitable for very different
applications. Polyunsaturated fatty acids such as linoleic acid and linolenic acid are essential for mammals, since they
cannot be produced by the latter. Polyunsaturated ω3-fatty acids and ω6-fatty acids are therefore an important constituent
in animal and human nutrition.
[0003] Hereinbelow, polyunsaturated fatty acids are referred to as PUFA, PUFAs, LCPUFA or LCPUFAs (poly un-
saturated fatty acids, PUFA, long chain poly unsaturated fatty acids, LCPUFA).
[0004] The various fatty acids and triglycerides are mainly obtained from microorganisms such as Mortierella and
Schizochytrium or from oil-producing plants such as soybean, oilseed rape, algae such as Crypthecodinium or Phaeo-
dactylum and others, where they are obtained, as a rule, in the form of their triacylglycerides (= triglycerides = triglycerols).
However, they can also be obtained from animals, such as, for example, fish. The free fatty acids are advantageously
prepared by hydrolysis. Very long-chain polyunsaturated fatty acids such as docosahexaenoic acid (= DHA, C22:
6∆4,7,10,13,16,19), eicosapentaenoic acid (= EPA, C20:5∆5,8,11,14,17), arachidonic acid (= ARA, C20:4∆5,8,11,14), dihomo-
γ-linolenic acid (C20-3∆8,11,14) or docosapentaenoic acid (DPA, C22:5∆7,10,13,16,19) are not synthesized in oil crops such
as oilseed rape, soybean, sunflower or safflower. Conventional natural sources of these fatty acids are fish such as
herring; salmon, sardine, redfish, eel, carp, trout, halibut, mackerel, zander or tuna, or algae.
[0005] Depending on the intended use, oils with saturated or unsaturated fatty acids are preferred. In human nutrition,
for example, lipids with unsaturated fatty acids, specifically polyunsaturated fatty acids, are preferred. The polyunsatu-
rated ω3-fatty acids are said to have a positive effect on the cholesterol level in the blood and thus on the possibility of
preventing heart disease. The risk of heart disease, stroke or hypertension can be reduced markedly by adding these
ω3-fatty acids to the food. Also, ω3-fatty acids have a positive effect on inflammatory, specifically on chronically inflam-
matory, processes in association with immunological diseases such as rheumatoid arthritis. They are therefore added
to foodstuffs, specifically to dietetic foodstuffs, or are employed in medicaments. ω6-Fatty acids such as arachidonic
acid tend to have a negative effect on these disorders in connection with these rheumatic diseases on account of our
usual dietary intake.
[0006] ω3- and ω6-fatty acids are precursors of tissue hormones, known as eicosanoids, such as the prostaglandins,
which are derived from dihomo-γ-linolenic acid, arachidonic acid and eicosapentaenoic acid, and of the thromboxanes
and leukotrienes, which are derived from arachidonic acid and eicosapentaenoic acid. Eicosanoids (known as the PG2
series) which are formed from ω6-fatty acids generally promote inflammatory reactions, while eicosanoids (known as
the PG3 series) from ω3-fatty acids have little or no proinflammatory effect.
[0007] Owing to the positive characteristics of the polyunsaturated fatty acids, there has been no lack of attempts in
the past to make available genes which are involved in the synthesis of these fatty acids or triglycerides for the production
of oils in various organisms with a modified content of unsaturated fatty acids. Thus, WO 91/13972 and its US equivalent
describes a ∆9-desaturase. WO 93/11245 claims a ∆15-desaturase and WO 94/11516 a ∆12-desaturase. Further de-
saturases are described, for example, in EP-A-0 550 162, WO 94/18337, WO 97/30582, WO 97/21340, WO 95/18222,
EP-A-0 794 250, Stukey et al., J. Biol. Chem., 265, 1990: 20144-20149, Wada et al., Nature 347, 1990: 200-203 or
Huang et al., Lipids 34, 1999: 649-659. However, the biochemical characterization of the various desaturases has been
insufficient to date since the enzymes, being membrane-bound proteins, present great difficulty in their isolation and
characterization (McKeon et al., Methods in Enzymol. 71, 1981: 12141-12147, Wang et al., Plant Physiol. Biochem., 26,
1988: 777-792). As a rule, membrane-bound desaturases are characterized by being introduced into a suitable organism
which is subsequently analyzed for enzyme activity by analyzing the starting materials and the products. ∆6-Desaturases
are described in WO 93/06712, US 5,614,393, US5614393, WO 96/21022, WO 00/21557 and WO 99/27111 and the
application for the production of fatty acids in transgenic organisms is described in WO 98/46763, WO 98/46764 and
WO 98/46765. In this context, the expression of various desaturases and the formation of polyunsaturated fatty acids
is also described and claimed in WO 99/64616 or WO 98/46776. As regards the expression efficacy of desaturases and
its effect on the formation of polyunsaturated fatty acids, it must be noted that the expression of a single desaturase as
described to date has only resulted in low contents of unsaturated fatty acids/lipids such as, for example, γ-linolenic acid
and stearidonic acid. Moreover, a mixture of ω3- and ω6-fatty acids was obtained, as a rule.
[0008] Especially suitable microorganisms for the production of PUFAs are microalgae such as Phaeodactylum tri-
cornutum, Porphiridium species, Thraustochytrium species, Schizochytrium species or Crypthecodinium species, ciliates
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such as Stylonychia or Colpidium, fungae such as Mortierella, Entomophthora or Mucor and/or mosses such as Phys-
comitrella, Ceratodon and Marchantia (R. Vazhappilly & F. Chen (1998) Botanica Marina 41: 553-558; K. Totani & K.
Oba (1987) Lipids 22: 1060-1062; M. Akimoto et al. (1998) Appl. Biochemistry and Biotechnology 73: 269-278). Strain
selection has resulted in the development of a number of mutant strains of the microorganisms in question which produce
a series of desirable compounds including PUFAs. However, the mutation and selection of strains with an improved
production of a particular molecule such as the polyunsaturated fatty acids is a time-consuming and difficult process.
This is why recombinant methods as described above are preferred whenever possible.
[0009] However, only limited amounts of the desired polyunsaturated fatty acids such as DPA, EPA or ARA can be
produced with the aid of the abovementioned microorganisms, and, depending on the microorganism used, these are
generally obtained as fatty acid mixtures of, for example, EPA, DPA and ARA.
[0010] A variety of synthetic pathways is being discussed for the synthesis of arachidonic acid, eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA) (figure 1). Thus, EPA or DHA are produced in marine bacteria such as Vibrio
sp. or Shewanella sp. via the polyketide pathway (Yu, R. et al. Lipids 35:1061-1064, 2000; Takeyama, H. et al. Microbiology
143:2725-2731, 1997).
[0011] An alternative strategy is the alternating activity of desaturases and elongases (Zank, T.K. et al. Plant Journal
31:255-268, 2002; Sakuradani, E. et al. Gene 238:445-453, 1999). A modification of the above-described pathway by
∆6-desaturase, ∆6-elongase, ∆5-desaturase, ∆5-elongase and ∆4-desaturase is the Sprecher pathway (Sprecher 2000,
Biochim. Biophys. Acta 1486:219-231) in mammals. Instead of the ∆4-desaturation, a further elongation step is effected
here to give C24, followed by a further ∆6-desaturation and finally β-oxidation to give the C22 chain length. Thus what is
known as Sprecher pathway (see figure 1) is, however, not suitable for the production in plants and microorganisms
since the regulatory mechanisms are not known.
[0012] Depending on their desaturation pattern, the polyunsaturated fatty acids can be divided into two large classes,
viz. w6- or ω3-fatty acids, which differ with regard to their metabolic and functional activities (fig. 1).
[0013] The starting material for the ω6-metabolic pathway is the fatty acid linoleic acid (18:2∆9,12) while the ω3-pathway
proceeds via linolenic acid (18:3∆9,12,15). Linolenic acid is formed by the activity of an ω3-desaturase (Tocher et al. 1998,
Prog. Lipid Res. 37, 73-117 ; Domergue et al. 2002, Eur. J. Biochem. 269, 4105-4113).
[0014] Mammals, and thus also humans, have no corresponding desaturase activity (∆12- and ω3-desaturase) and
must take up these fatty acids (essential fatty acids) via the food. Starting with these precursors, the physiologically
important polyunsaturated fatty acids arachidonic acid (= ARA, 20:4∆5,8,11,14), an ω6-fatty acid and the two ω3-fatty acids
eicosapentaenoic acid (= EPA, 20:5∆5,8,11,14,17) and docosahexaenoic acid (DHA, 22:6∆4,7,10,13,17,19) are synthesized
via the sequence of desaturase and elongase reactions. The application of ω3-fatty acids shows the therapeutic activity
described above in the treatment of cardiovascular diseases (Shimikawa 2001, World Rev. Nutr. Diet. 88, 100-108),
Entzündungen (Calder 2002, Proc. Nutr. Soc. 61, 345-358) and Arthritis (Cleland and James 2000, J. Rheumatol. 27,
2305-2307).
[0015] The elongation of fatty acids, by elongases, by 2 or 4 C atoms is of crucial importance for the production of
C20- and C22-PUFAs, respectively. This process proceeds via 4 steps. The first step is the condensation of malonyl-
CoA with the fatty-acid-acyl-CoA by ketoacyl-CoA synthase (KCS, hereinbelow referred to as elongase). This is followed
by a reduction step (ketoacyl-CoA reductase, KCR), a dehydratation step (dehydratase) and a final reduction step (enoyl-
CoA reductase). It has been postulated that the elongase activity affects the specificity and rate of the entire process
(Millar and Kunst, 1997 Plant Journal 12:121-131).
[0016] There have been a large number of attempts in the past to obtain elongase genes. Millar and Kunst, 1997
(Plant Journal 12:121-131) and Millar et al. 1999, (Plant Cell 11:825-838) describe the characterization of plant elongases
for the synthesis of monounsaturated long-chain fatty acids (C22:1) and for the synthesis of very long-chain fatty acids
for the formation of waxes in plants (C28-C32). Descriptions regarding the synthesis of arachidonic acid and EPA are
found, for example, in WO0159128, WO0012720, WO02077213 and WO0208401. The synthesis of polyunsaturated
C24-fatty acids is described, for example, in Tvrdik et al. 2000, JCB 149:707-717 or WO0244320.
[0017] Higher plants comprise polyunsaturated fatty acids such as linoleic acid (18:2∆9,12) and linolenic acid (18:
3∆9,12,15). ARA, EPA and DHA are found not at all in the seed oil of higher plants, or only in miniscule amounts (E.
Ucciani: Nouveau Dictionnaire des Huiles Végétales [New Dictionary of Vegetable Oils]. Technique & Documentation-
Lavoisier, 1995. ISBN: 2-7430-0009-0). However, the production of LCPUFAs in higher plants, preferably in oil crops
such as oilseed rape, linseed, sunflower and soybeans, would be advantageous since large amounts of high-quality
LCPUFAs for the food industry, animal nutrition and pharmaceutical purposes might be obtained economically. To this
end, it is advantageous to introduce, into oil crops, genes which encode enzymes of the LCPUFA biosynthesis via
recombinant methods and to express them therein. These genes may encode for example ∆9-elongases, ∆8-desaturases
and/or ∆5-desaturases. These genes can advantageously be isolated from microorganisms and lower plants which
produce LCPUFAs and incorporate them in the membranes or triacylglycerides. Thus, it has already been possible to
isolate ∆6-desaturase genes from the moss Physcomitrella patens and ∆6-elongase genes from P. patens and from the
nematode C. elegans.
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[0018] The first transgenic plants which comprise and express genes encoding LCPUFA biosynthesis enzymes and
which, as a consequence, produce LCPUFAs were described for the first time, for example, in DE-A-102 19 203 (process
for the production of polyunsaturated fatty acids in plants). However, these plants produce LCPUFAs in amounts which
require further optimization for processing the oils which are present in the plants.
[0019] As can be seen from Figure 1, products of the ω6-pathway can be modified using appropriate desaturases
and, if necessary, elongases to give ω3 fatty acids. Therefore, it would be exceedingly valuable to develop a product
which makes possible the production of ARA in a genetically modified organism.
[0020] The oyster protozoan parasite Perkinsus marinusi is capable of synthesizing saturated and unsaturated fatty
acids, including the essential fatty acid, arachidonic acid [20:4(n-6), via the ∆-8 desaturase pathway. Surprisingly the
present inventors have found that P. marinusi contains nucleic encoding a ∆9-elongase, a ∆8-desaturase and a ∆5-
desaturase which can all be transcribed as a single transcript. The full length sequence is shown as SEQ ID NO: 1.
[0021] According to a first aspect of the present invention there is provided an isolated nucleic acid molecule which
encodes a polypeptide with ∆9-elongase activity and which is selected from the group consisting of:
a) a sequence comprising nucleic acid residues 7668 to 9200 of SEQ ID NO: 1;
b) an isolated nucleic acid sequence which encodes a polypeptide with ∆9-elongase activity, wherein the polypeptide
comprises SEQ ID NO: 2;
c) a derivative of a sequence comprising nucleic acid residues 7668 to 9200 of SEQ ID NO: 1 which encodes a
polypeptide with at least 85% identity at the amino acid level with SEQ ID NO: 2 over the entire length of SEQ ID
NO: 2; wherein said polypeptide has ∆9-elongase activity.
[0022] There is also described an isolated nucleic acid
sequence which encodes polypeptides with ∆9-elongase, ∆8-desaturase and ∆5-desaturase activity and which is selected
from the group consisting of:
a) Anuclei acid sequence comprising nucleic acid residues 7668 to 12077 of SEQ ID NO: 1 or a homolog thereof;
b) a nucleic acid sequence which hybridizes under stringent conditions with a nucleic acid sequence comprising
nucleic acid residues 7668 to 12077 of SEQ ID NO: 1;
c) an isolated nucleic acid sequence which encodes polypeptides with ∆9-elongase, ∆8-desaturase and ∆5-desat-
urase activity, wherein the polypeptides are selected from the group consisting of SEQ ID NOS 2, 3 and 4;
d) A derivative of a nucleic acid sequence of SEQ ID NO: 1 which encodes polypeptides with at least 40% identity
at the amino acid level with SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO: 4; wherein said polypeptides have ∆9-
elongase, ∆8-desaturase and ∆5-desaturase activity.
[0023] The advantage of the nucleic acid sequence described above is that, although it encodes three separate
enzymes, it can be transcribed as a single sequence, which makes it much simpler to prepare cloning and expression
vectors expressing all three enzymes.
[0024] The isolated nucleic acid sequence may not be identical to SEQ ID No 1 (sequence 1047306867) itself.
[0025] In the context of the present invention "hybridizes under stringent conditions" is intended to describe hybridization
and washing conditions under which nucleotide sequences with at least 60% homology to one another usually remain
hybridized with one another. Conditions are preferably such that sequences with at least approximately 65%, preferably
at least approximately 70% and especially preferably at least 75% or more homology to one another usually remain
hybridized to one another. These stringent conditions are known to the skilled worker and described, for example, in
Current Protocols in Molecular Biology, John Wiley & Sons, N. Y. (1989), 6.3.1-6.3.6. A preferred nonlimiting example
of stringent hybridization conditions is hybridizations in 6 x sodium chloride/sodium citrate (= SSC) at approximately
45°C, followed by one or more washing steps in 0.2 x SSC, 0.1 % SDS at 50 to 65°C. The skilled worker knows that
these hybridization conditions differ depending on the type of nucleic acid and, for example when organic solvents are
present, regarding temperature and buffer concentration. Under "standard hybridization conditions", for example, the
hybridization temperature is, depending on the type of nucleic acid, between 42°C and 58°C in aqueous buffer with a
concentration of 0.1 to 5 x SSC (pH 7.2). If organic solvents, for example 50% formamide, are present in the above-
mentioned buffer, the temperature under standard conditions is approximately 42°C. The hybridization conditions for
DNA:DNA hybrids, for example, are 0.1 x SSC and 20°C to 45°C, preferably 30°C to 45°C. The hybridization conditions
for DNA:RNA hybrids are, for example, 0.1 x SSC and 30°C to 55°C, preferably 45°C to 55°C. The abovementioned
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hybridization conditions are determined by way of example for a nucleic acid with approximately 100 bp (= base pairs)
in length and with a G + C content of 50% in the absence of formamide. The skilled worker knows how to determine the
required hybridization conditions on the basis of the abovementioned textbooks or textbooks such as Sambrook et al.,
"Molecular Cloning", Cold Spring Harbor Laboratory, 1989; Hames and Higgins (Ed.) 1985, "Nucleic Acids Hybridization:
A Practical Approach", IRL Press at Oxford University Press, Oxford; Brown (Ed.) 1991, "Essential Molecular Biology:
A Practical Approach", IRL Press at Oxford University Press, Oxford.
[0026] Furthermore, when the present specification refers to isolated nucleic acid molecules of a nucleotide sequence
which hybridize with one of the nucleotide sequences shown in SEQ ID NO: 1, SEQ ID NO: 3 or with a part thereof
under stringent conditions, "a part thereof" is understood as meaning, in accordance with the invention, that at least 25
base pairs (= bp), 50 bp, 75 bp, 100 bp, 125 bpor 150 bp, preferably at least 175 bp, 200 bp, 225 bp, 250 bp, 275 bp or
300 bp, especially preferably 350 bp, 400 bp, 450 bp, 500 bp or more base pairs are used for the hybridization.
[0027] In the context of the present invention "Homologs" of the nucleic acid sequence with the sequence SEQ ID
NO: 1 means, for example, allelic variants with at least approximately 50 or 60%, preferably at least approximately 60
or 70%, more preferably at least approximately 70 or 80%, 90% or 95% and even more preferably at least approximately
85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95 %, 96%, 97%, 98%, 99% or more identity or homology
with a nucleotide sequence shown in SEQ ID NO: 1.
[0028] "Allelic variants" comprise in particular functional variants which can be obtained by deletion, insertion or
substitution of nucleotides from/into the sequence, it being intended, however, that the enzyme activity of the resulting
proteins which are synthesized is advantageously retained for the insertion of one or more genes.
[0029] "Homologs" also means bacterial, fungal and plant homologs, truncated sequences, single-stranded DNA or
RNA of the coding and noncoding DNA sequence and derivatives such as, for example, promoter variants. The promoters
upstream of the nucleotide sequences detailed can be modified by one or more nucleotide exchanges, by insertion(s)
and/or deletion(s) without the functionality or activity of the promoters being adversely affected, however. It is furthermore
possible that the modification of the promoter sequence enhances their activity or that they are replaced entirely by more
active promoters, including those from heterologous organisms.
[0030] In order to determine the percentage of homology (= identity) of two amino acid sequences, the sequences
are written one under the other for an optimal comparison (for example, gaps may be introduced into the sequence of
a protein or of a nucleic acid in order to generate an optimal alignment with the other protein or the other nucleic acid).
Then, the amino acid residue or nucleotides at the corresponding amino acid positions or nucleotide positions are
compared. If a position in a sequence is occupied by the same amino acid residue or the same nucleotide as the
corresponding position in the other sequence, then the molecules are homologous at this position (i.e. amino acid or
nucleic acid "homology" as used in the present context corresponds to amino acid or nucleic acid "identity"). The per-
centage of homology between the two sequences is a function of the number of positions which the sequences share
(i.e. % homology = number of identical positions/total number of positions x 100). The terms homology and identity are
therefore to be considered as synonymous.
[0031] The homology was calculated over the entire amino acid or nucleic acid sequence region. The skilled worker
has available a series of programs which are based on various algorithms for the comparison of various sequences.
Here, the algorithms of Needleman and Wunsch or Smith and Waterman give particularly reliable results. The program
PileUp (J. Mol. Evolution., 25, 351-360, 1987, Higgins et al., CABIOS, 5 1989: 151-153) or the programs Gap and BestFit
[Needleman and Wunsch (J. Mol. Biol. 48; 443-453 (1970) and Smith and Waterman (Adv. Appl. Math. 2; 482-489
(1981)], which are part of the GCG software packet [Genetics Computer Group, 575 Science Drive, Madison, Wisconsin,
USA 53711 (1991)], were used for the sequence alignment. The sequence 0gy values which are indicated above as a
percentage were determined over the entire sequence region using the program GAP and the following settings: Gap
Weight: 50, Length Weight: 3, Average Match: 10.000 and Average Mismatch: 0.000. Unless otherwise specified, these
settings were always used as standard settings for the sequence alignments.
[0032] In the context of the present invention "∆9-elongase, ∆8-desaturase and ∆5-desaturase activity" is understood
as meaning that a protein encoded by a derivative of SEQ ID NO:1 or nucleic acid residues 7668 to 12077 of SEQ ID
NO: 1 retains an enzymatic activity of at least 10%, preferably 20%, especially preferably 30% and very especially 40%
in comparison with the proteins/enzymes encoded by the sequence SEQ ID NO: 1 or nucleic acid residues 7668 to
12077 of SEQ ID NO: 1 and can thus catalyse the conversion of linoleic acid to arachidonic acid.
[0033] Although it is often extremely useful to transcribe nucleic acid encoding polypeptides with ∆9-elongase, ∆8-
desaturase and ∆5-desaturase activity as a single sequence, there may be some circumstances in which it is preferable
to make use of nucleic acid encoding a single enzyme, i.e. a ∆9-elongase, a ∆8-desaturase or a ∆5-desaturase.
[0034] In this regard, the present invention relates to an isolated nucleic acid sequence according to the first aspect
of the invention which encodes a polypeptide with ∆9-elongase activity.
[0035] There is also described an isolated nucleic acid sequence which encodes a polypeptide with ∆8-desaturase
activity and which is selected from the group consisting of:
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a) a sequence comprising nucleic acid residues 9351 to 10724 of SEQ ID NO: 1 or a homolog thereof;
b) nucleic acid sequences which hybridize under stringent conditions with a nucleic acid sequence comprising
residues 9351 to 10724 of SEQ ID NO: 1;
c) an isolated nucleic acid sequence which encodes polypeptides with ∆8-desaturase activity, wherein the polypeptide
comprises SEQ ID NO: 3;
d) A derivative of a a sequence comprising nucleic acid residues 9351 to 10724 of SEQ ID NO: 1 which encodes a
polypeptide with at least 40% identity at the amino acid level with SEQ ID NO: 3; wherein said polypeptide has ∆8-
desaturase activity.
[0036] There is also described an isolated nucleic acid sequence
which encodes a polypeptide with ∆5-desaturase activity and which is selected from the group consisting of:
a) a sequence comprising nucleic acid residues 10842 to 12077 of SEQ ID NO: 1 or a homolog thereof;
b) nucleic acid sequences which hybridize under stringent conditions with a nucleic acid sequence comprising
residues 10842 to 12077 of SEQ ID NO: 1;
c) an isolated nucleic acid sequence which encodes polypeptides with ∆5-desaturase activity, wherein the polypeptide
comprises SEQ ID NO: 4;
d) A derivative of a a sequence comprising nucleic acid residues 10842 to 12077 of SEQ ID NO: 1 which encodes
a polypeptide with at least 40% identity at the amino acid level with SEQ ID NO: 4; wherein said polypeptide has
∆5-desaturase activity.
[0037] In another aspect of the invention there is provided a polypeptide which is encoded by a nucleic acid sequence
of the first aspect of the invention.
[0038] Advantageously, the polypeptide encoded by the nucleic acid molecule of the present invention has at least
85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more identity with the amino
acid sequences shown in SEQ ID NO: 2.
[0039] The nucleic acid sequences of the present invention are advantageously introduced into an expression cassette
which makes possible the expression of the nucleic acids in organisms such as microorganisms or plants.
[0040] Therefore, in another aspect of the invention there is provided a gene construct comprising a nucleic acid
sequence which encodes ∆9-elongase activity as set out above, operably linked with one or more regulatory sequences.
[0041] In the expression cassette, the nucleic acid sequence which encodes ∆9-elongase and optionally ∆8 desaturase
and/or ∆5-desaturase, is linked operably with one or more regulatory sequences, advantageously for enhancing gene
expression. These regulatory sequences are intended to make possible the specific expression of the genes and proteins.
Depending on the host organism, this may mean, for example, that the gene is expressed and/or overexpressed only
after induction has taken place, or else that it is expressed and/or overexpressed immediately. For example, these
regulatory sequences take the form of sequences to which inductors or repressors bind, thus controlling the expression
of the nucleic acid. In addition to these novel regulatory sequences, or instead of these sequences, the natural regulatory
elements of these sequences may still be present before the actual structural genes and, if appropriate, may have been
genetically modified in such a way that their natural regulation is eliminated and the expression of the genes is enhanced.
However, the expression cassette (= expression construct = gene construct) can also be simpler in construction, that is
to say no additional regulatory signals have been inserted before the nucleic acid sequence or its derivatives, and the
natural promoter together with its regulation was not removed. Instead, the natural regulatory sequence has been mutated
in such a way that regulation no longer takes place and/or gene expression is enhanced. These modified promoters can
also be positioned on their own before the natural gene in the form of part-sequences (= promotor with parts of the
nucleic acid sequences used in accordance with the invention) in order to enhance the activity. Moreover, the gene
construct may advantageously also comprise one or more what are known as enhancer sequences in operable linkage
with the promoter, which make possible an enhanced expression of the nucleic acid sequence.
[0042] Additional advantageous sequences, such as further regulatory elements or terminator sequences, may also
be inserted at the 3’ end of the DNA sequences. One or more sequences encoding enzymes which catalyse the conversion
of ARA to an ω3-unsaturated fatty acid such as EPA or DHA may also be present. Thus, for example, sequences
encoding a ∆5-elongase, ω3-desaturase and/or ∆4-desaturase, may be present in one or more copies of the expression
cassette (= gene construct). Preferably, only one copy of the genes is present in each expression cassette. This gene
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construct or the gene constructs can be expressed together in the host organism. In this context, the gene construct(s)
can be inserted in one or more vectors and be present in the cell in free form, or else be inserted in the genome. It is
advantageous for the insertion of further genes in the genome when the genes to be expressed are present together in
one gene construct.
[0043] In this context, the regulatory sequences or factors can, as described above, preferably have a positive effect
on the gene expression of the genes introduced, thus enhancing it. Thus, an enhancement of the regulatory elements,
advantageously at the transcriptional level, may take place by using strong transcription signals such as promoters
and/or enhancers. In addition, however, enhanced translation is also possible, for example by improving the stability of
the mRNA.
[0044] The regulatory sequences include, in particular, plant sequences such as promoter and terminator sequences.
The constructs can advantageously be stably propagated in microorganisms, in particular in E. coli and Agrobacterium
tumefaciens, under selective conditions and make possible the transfer of heterologous DNA into plants or microorgan-
isms.
[0045] Useful regulatory sequences are present, for example, in promoters such as the cos, tac, trp, tet, trp-tet, lpp,
lac, lpp-lac, laciq, T7, T5, T3, gal, trc, ara, SP6, λ-PR or λ-PL promoter and are advantageously employed in Gram-
negative bacteria. Further advantageous regulatory sequences are, for example, present in the Gram-positive promoters
amy and SPO2, in the yeast or fungal promoters ADC1, MFα, AC, P-60, CYC1, GAPDH, TEF, rp28, ADH or in the plant
promoters CaMV/35S [Franck et al., Cell 21 (1980) 285-294], PRP1 [Ward et al., Plant. Mol. Biol. 22 (1993)], SSU, OCS,
lib4, usp, STLS1, B33, nos or in the ubiquitin or phaseolin promoter. Advantageous in this context are also inducible
promoters, such as the promoters described in EP-A-0 388 186 (benzenesulfonamide-inducible), Plant J. 2, 1992:
397-404 (Gatz et al., tetracycline-inducible), EP-A-0 335 528 (abscissic acid-inducible) or WO 93/21334 (ethanol- or
cyclohexenol-inducible) promoters. Further suitable plant promoters are the cytosolic FBPase promoter or the ST-LSI
promoter of potato (Stockhaus et al., EMBO J. 8, 1989, 2445), the glycine max phosphoribosylpyrophosphate ami-
dotransferase promoter (Genbank Accession No.. U87999) or the node-specific promoter described in EP-A-0 249 676.
[0046] Especially advantageous promoters are promoters which make possible the expression in tissues which are
involved in the biosynthesis of fatty acids. Very especially advantageous are seed-specific promoters, such as the USP
promoter as described, but also other promoters such as the LeB4, DC3, phaseolin or napin promoter. Further especially
advantageous promoters are seed-specific promoters which can be used for monocotyledonous or dicotyledonous plants
and which are described in US 5,608,152 (oilseed rape napin promoter), WO 98/45461 (Arabidopsis oleosin promoter),
US 5,504,200 (Phaseolus vulgaris phaseolin promoter), WO 91/13980 (Brassica Bce4 promoter), by Baeumlein et al.,
Plant J., 2, 2, 1992:233-239 (LeB4 promoter from a legume), these promoters being suitable for dicots. Examples of
promoters which are suitable for monocots are the barley lpt-2 or lpt-1 promoter (WO 95/15389 and WO 95/23230), the
barley hordein promoter and other suitable promoters described in WO 99/16890.
[0047] In principle, it is possible to use all natural promoters together with their regulatory sequences, such as those
mentioned above. It is also possible and advantageous to use synthetic promoters, either in addition or alone, in particular
when they mediate seed-specific expression, such as those described in WO 99/16890.
[0048] In order to achieve a particularly high ARA content, especially in transgenic plants, the genes should advan-
tageously be expressed in oil crops in a seed-specific manner. To this end, seed-specific promoters can be used, or
those promoters which are active in the embryo and/or in the endosperm. In principle, seed-specific promoters can be
isolated both from dicotyledonous and from monocotyledonous plants. Preferred promoters are listed hereinbelow: USP
(= unknown seed protein) and vicilin (Vicia faba) [Bäumlein et al., Mol. Gen Genet., 1991, 225(3)], napin (oilseed rape)
[US 5,608,152], acyl carrier protein (oilseed rape) [US 5,315,001 and WO 92/18634], oleosin (Arabidopsis thaliana) [WO
98/45461 and WO 93/20216], phaseolin (Phaseolus vulgaris) [US 5,504,200], Bce4 [WO 91/13980], legumines B4
(LegB4 promoter) [Bäumlein et al., Plant J., 2,2, 1992], Lpt2 and lpt1 (barley) [WO 95/15389 and WO95/23230], seed-
specific promoters from rice, maize and wheat [WO 99/16890], Amy32b, Amy 6-6 and aleurain [US 5,677,474], Bce4
(oilseed rape) [US 5,530,149], glycinin (soybean) [EP 571 741], phosphoenol pyruvate carboxylase (soybean) [JP
06/62870], ADR12-2 (soybean) [WO 98/08962], isocitrate lyase (oilseed rape) [US 5,689,040] or α-amylase (barley)
[EP 781 849].
[0049] Plant gene expression can also be facilitated via a chemically inducible promoter (see review in Gatz 1997,
Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108). Chemically inducible promoters are particularly suitable when it
is desired that gene expression should take place in a time-specific manner. Examples of such promoters are a salicylic-
acid-inducible promoter (WO 95/19443), a tetracycline-inducible promoter (Gatz et al. (1992) Plant J. 2, 397-404) and
an ethanol-inducible promoter.
[0050] To ensure the stable integration of the biosynthesis genes into the transgenic plant over a plurality of generations,
it is usually necessary for each of the nucleic acids which encodes a protein of interest to be expressed under the control
of a separate promoter, preferably a promoter which differs from the other promoters, since repeating sequence motifs
can lead to instability of the T-DNA, or to recombination events.
[0051] Sequences encoding ∆9-elongase, ∆8-desaturase and ∆5-desaturase can be transcribed as a single unit
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needing only one promoter. It will, of course, be necessary for other genes encoding, for example, ∆5-elongase, ω3-
desaturase and/or ∆4-desaturase to be under the control of separate promoters.
[0052] In this context, the expression cassette is advantageously constructed in such a way that a promoter is followed
by a suitable cleavage site, advantageously in a polylinker, for insertion of the nucleic acid to be expressed and, if
appropriate, a terminator sequence is positioned behind the polylinker. This sequence is repeated several times, pref-
erably three, four or five times, so that up to five genes can be combined in one construct and introduced into the
transgenic plant in order to be expressed. Advantageously, the sequence is repeated up to three times. To express the
nucleic acid sequences, the latter are inserted behind the promoter via a suitable cleavage site, for example in the
polylinker. Advantageously, each nucleic acid sequence has its own promoter and, if appropriate, its own terminator
sequence. Such advantageous constructs are disclosed, for example, in DE 101 02 337 or DE 101 02 338. However,
it is also possible to insert a plurality of nucleic acid sequences behind a promoter and, if appropriate, before a terminator
sequence. Here, the insertion site, or the sequence, of the inserted nucleic acids in the expression cassette is not of
critical importance, that is to say a nucleic acid sequence can be inserted at the first or last position in the cassette
without its expression being substantially influenced thereby. Advantageously, different promoters such as, for example,
the USP, LegB4 or DC3 promoter, and different terminator sequences can be used in the expression cassette. However,
it is also possible to use only one type of promoter in the cassette. This, however, may lead to undesired recombination
events.
[0053] As described above, the transcription of the genes which have been introduced should advantageously be
terminated by suitable terminator sequences at the 3’ end of the biosynthesis genes which have been introduced (behind
the stop codon). An example of a sequence which can be used in this context is the OCS 1 terminator sequence. As is
the case with the promoters, different terminator sequences should be used for each gene.
[0054] The gene construct of the present invention may also comprise biosynthesis genes of the fatty acid or lipid
metabolism selected from the group acyl-CoA dehydrogenase(s), acyl-ACP [= acyl carrier protein] desaturase(s), acyl-
ACP thioesterase(s),fatty acid acyltransferase(s), acyl-CoA:lysophospholipid acyltransferase(s), fatty acid synthase(s),
fatty acid hydroxylase(s), acetyl-coenzyme A carboxylase(s), acyl-coenzyme A oxidase(s), fatty acid desaturase(s), fatty
acid acetylenases, lipoxygenases, triacylglycerol lipases, allenoxide synthases, hydroperoxide lyases or fatty acid elon-
gase(s) and desaturase(s) such as ∆4-desaturase, ∆5-desaturase, ∆6-desaturase, ∆8-desaturase, ∆9-desaturase, ∆12-
desaturase or ∆6-elongase.
[0055] These additional nucleic acids or genes can be cloned into the expression cassettes, which are then used for
transforming plants with the aid of vectors such as Agrobacterium.
[0056] Here, the regulatory sequences or factors can, as described above, preferably have a positive effect on, and
thus enhance, the expression genes which have been introduced. Thus, enhancement of the regulatory elements can
advantageously take place at the transcriptional level by using strong transcription signals such as promoters and/or
enhancers. However, an enhanced translation is also possible, for example by improving the stability of the mRNA. In
principle, the expression cassettes can be used directly for introduction into the plants or else be introduced into a vector.
[0057] Therefore, in yet another aspect of the invention, there is provided a vector comprising a nucleic acid or a gene
construct in any of the aspects of the invention described above.
[0058] In one embodiment, the vector may be a cloning vector.
[0059] The nucleic acid sequence(s) of the invention may be introduced alone, or preferably, in combination with an
expression cassette (nucleic acid construct) into an organism. To introduce the nucleic acids, the latter are advantageously
amplified and ligated in the known manner. Preferably, a procedure following the protocol for Pfu DNA polymerase or
a Pfu/Taq DNA polymerase mixture is followed. The primers are selected taking into consideration the sequence to be
amplified. The primers should advantageously be chosen in such a way that the amplificate comprises the entire co-
dogenic sequence from the start codon to the stop codon. After the amplification, the amplificate is expediently analyzed.
For example, a gel-electrophoretic separation can be carried out, which is followed by a quantitative and a qualitative
analysis. Thereafter, the amplificate can be purified following a standard protocol (for example Qiagen). An aliquot of
the purified amplificate is then available for the subsequent cloning step.
[0060] Suitable cloning vectors are generally known to the skilled worker. These include, in particular, vectors which
are capable of replication in microbial systems, that is to say mainly vectors which ensure efficient cloning in yeasts or
fungi and which make possible the stable transformation of plants. Those which must be mentioned in particular are
various binary and cointegrated vector systems which are suitable for the T-DNA-mediated transformation. Such vector
systems are, as a rule, characterized in that they comprise at least the vir genes required for the Agrobacterium-mediated
transformation and the T-DNA-delimiting sequences (T-DNA border). These vector systems advantageously also com-
prise further cis-regulatory regions such as promoters and terminator sequences and/or selection markers, by means
of which suitably transformed organisms can be identified. While in the case of cointegrated vector systems vir genes
and T-DNA sequences are arranged on the same vector, binary systems are based on at least two vectors, one of which
bears vir genes, but no T-DNA, while a second one bears T-DNA, but no vir gene. Owing to this fact, the last-mentioned
vectors are relatively small, easy to manipulate and to replicate both in E. coli and in Agrobacterium. These binary vectors
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include vectors from the series pBIB-HYG, pPZP, pBecks, pGreen. In accordance with the invention; Bin19, pBl101,
pBinAR, pGPTV and pCAMBIA are used by preference. An overview of the binary vectors and their use is found in
Hellens et al, Trends in Plant Science (2000) 5, 446-451. In order to prepare the vectors, the vectors can first be linearized
with restriction endonuclease(s) and then modified enzymatically in a suitable manner. Thereafter, the vector is purified,
and an aliquot is employed for the cloning step. In the cloning step, the enzymatically cleaved and, if appropriate, purified
amplificate is cloned with vector fragments which have been prepared in a similar manner, using ligase. In this context,
a particular nucleic acid construct, or vector or plasmid construct, can have one or else more than one codogenic gene
segment. The codogenic gene segments in these constructs are preferably linked operably with regulatory sequences.
The regulatory sequences include, in particular, plant sequences such as the above-described promoters and terminator
sequences. The constructs can advantageously be stably propagated in microorganisms, in particular in E. coli and
Agrobacterium tumefaciens, under selective conditions and make possible the transfer of heterologous DNA into plants
or microorganisms.
[0061] The nucleic acids of the invention can be introduced into organisms such as microorganisms or advantageously
plants, advantageously using cloning vectors, and thus be used in the transformation of plants such as those which are
published and cited in: Plant Molecular Biology and Biotechnology (CRC Press, Boca Raton, Florida), Chapter 6/7, p.
71-119 (1993); F.F. White, Vectors for Gene Transfer in Higher Plants; in: Transgenic Plants, Vol. 1, Engineering and
Utilization, Ed.: Kung and R. Wu, Academic Press, 1993, 15-38; B. Jenes et al., Techniques for Gene Transfer, in:
Transgenic Plants, Vol. 1, Engineering and Utilization, Ed.: Kung and R. Wu, Academic Press (1993), 128-143; Potrykus,
Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991), 205-225. Thus, the nucleic acids, the inventive nucleic acids and
nucleic acid constructs, and/or vectors used in the process can be used for the recombinant modification of a broad
spectrum of organisms, advantageously plants, so that the latter become better and/or more efficient producers of ARA.
[0062] A series of mechanisms exist by which modification of the ∆9-elongase, ∆8-desaturase and ∆5-desaturase
proteins is possible, so that the yield, production and/or production efficiency of ARA in a plant, preferably in an oil crop
plant or a microorganism, can be influenced directly owing to these modified proteins. The number or activity of the
proteins or genes can be increased, so that greater amounts of the gene products and, ultimately, greater amounts of
the compounds of the general formula I are produced. A de novo synthesis in an organism which has lacked the activity
and ability to biosynthesize the compounds prior to introduction of the corresponding gene(s) is also possible. This
applies analogously to the combination with further desaturases or elongases or further enzymes of the fatty acid and
lipid metabolism. The use of various divergent sequences, i.e. sequences which differ at the DNA sequence level, may
also be advantageous in this context, or else the use of promoters for gene expression which make possible a different
gene expression in the course of time, for example as a function of the degree of maturity of a seed or an oil-storing tissue.
[0063] Owing to the introduction of a gene encoding ∆9-elongase, ∆8-desaturase and/or ∆5-desaturase into an or-
ganism, alone or in combination with other genes in a cell, it is not only possible to increase biosynthesis flux towards
the end product, but also to increase, or to create de novo the corresponding triacylglycerol composition. Likewise, the
number or activity of other genes which are involved in the import of nutrients which are required for the biosynthesis of
one or more fatty acids, oils, polar and/or neutral lipids, can be increased, so that the concentration of these precursors,
cofactors or intermediates within the cells or within the storage compartment is increased, whereby the ability of the
cells to produce ARA as described below is enhanced further. By optimizing the activity or increasing the number of one
or more genes encoding ∆9-elongase, ∆8-desaturase and/or ∆5-desaturase which are involved in the biosynthesis ARA,
or by destroying the activity of one or more genes which are involved in the degradation of ARA, an enhanced yield,
production and/or efficiency of production of fatty acid and lipid molecules in organisms, advantageously in plants, is
made possible.
[0064] Nucleic acids which can advantageously be used in the process are derived from bacteria, fungi, diatoms,
animals such as Caenorhabditis or Oncorhynchus or plants such as algae or mosses, such as the genera Shewanella,
Physcomitrella, Thraustochytrium, Fusarium, Phytophthora, Ceratodon, Mantoniella, Ostreococcus, Isochrysis, Aleurita,
Muscarioides, Mortierella, Borago, Phaeodactylum, Crypthecodinium, specifically from the genera and species Onco-
rhynchus mykiss, Xenopus laevis, Ciona intestinalis, Thalassiosira pseudonona, Mantoniella squamata, Ostreococcus
sp., Ostreococcus tauri, Euglena gracilis, Physcomitrella patens, Phytophtora infestans, Fusarium graminaeum, Cryp-
tocodinium cohnii, Ceratodon purpureus, Isochrysis galbana, Aleurita farinosa, Thraustochytrium sp., Muscarioides
viallii, Mortierella alpina, Borago officinalis, Phaeodactylum tricornutum, Caenorhabditis elegans or especially advan-
tageously from Oncorhynchus mykiss, Euglena gracilis, Thalassiosira pseudonona or Crypthecodinium cohnii.
[0065] In an alternative embodiment, the vector may be an expression vector designed to transform an organism in
which the nucleic acid is to be expressed and linoleic acid converted to ARA.
[0066] These advantageous vectors, preferably expression vectors, comprise the nucleic acid(s) which encode the
∆9-elongase and optionally ∆8-desaturase and/or ∆5-desaturase and which are described above.
[0067] As used in the present context, the term "vector" refers to a nucleic acid molecule which is capable of transporting
another nucleic acid to which it is bound. One type of vector is a "plasmid", a circular double-stranded DNA loop into
which additional DNA segments can be ligated. A further type of vector is a viral vector, it being possible for additional
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DNA segments to be ligated into the viral genome. Certain vectors are capable of autonomous replication in a host cell
into which they have been introduced (for example bacterial vectors with bacterial replication origin). Other vectors are
advantageously integrated into the genome of a host cell when they are introduced into the host cell, and thus replicate
together with the host genome. Moreover, certain vectors can govern the expression of genes with which they are in
operable linkage. These vectors are referred to in the present context as "expression vectors". Usually, expression
vectors which are suitable for DNA recombination techniques take the form of plasmids.
[0068] In the present description, where the term "plasmid" is used, it should be understood that plasmids can be
substituted for other types of expression vector, such as viral vectors, which exert similar functions. Furthermore, the
term "vector" is also intended to comprise other vectors with which the skilled worker is familiar, such as phages, viruses
such as SV40, CMV, TMV, transposons, IS elements, phasmids, phagemids, cosmids, linear or circular DNA.
[0069] The recombinant expression vectors advantageously used in the process comprise the nucleic acids described
below or the above-described gene construct in a form which is suitable for expressing the nucleic adds used in a host
cell, which means that the recombinant expression vectors comprise one or more regulatory sequences, selected on
the basis of the host cells used for the expression, which regulatory sequence(s) is/are linked operably with the nucleic
acid sequence to be expressed. In a recombinant expression vector, "linked operably" means that the nucleotide se-
quence of interest is bound to the regulatory sequence(s) in such a way that the expression of the nucleotide sequence
is possible and they are bound to each other in such a way that both sequences carry out the predicted function which
is ascribed to the sequence (for example in an in-vitro transcription/translation system, or in a host cell if the vector is
introduced into the host cell). The term "regulatory sequence" is intended to comprise promoters, enhancers and other
expression control elements (for example polyadenylation signals). These regulatory sequences are described, for
example, in Goeddel: Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, CA
(1990), or see: Gruber and Crosby, in: Methods in Plant Molecular Biology and Biotechnolgy, CRC Press, Boca Raton,
Florida, Ed.: Glick and Thompson, Chapter 7, 89-108, including the references cited therein. Regulatory sequences
comprise those which govern the constitutive expression of a nucleotide sequence in many types of host cell and those
which govern the direct expression of the nucleotide sequence only in specific host cells under specific conditions. The
skilled worker knows that the design of the expression vector can depend on factors such as the choice of host cell to
be transformed, the desired expression level of the protein and the like.
[0070] The recombinant expression vectors used can be designed for the expression of ∆9-elongase, ∆8-desaturase
and/or ∆5-desaturase in prokaryotic or eukaryotic cells. This is advantageous since intermediate steps of the vector
construction are frequently carried out in microorganisms for the sake of simplicity. For example, the ∆9-elongase, ∆8-
desaturase and/or ∆5-desaturase gene can be expressed in bacterial cells, insect cells (using Baculovirus expression
vectors), yeast and other fungal cells (see Romanos, M.A., et al. (1992) "Foreign gene expression in yeast: a review",
Yeast 8:423-488; van den Hondel, C.A.M.J.J., et al. (1991) "Heterologous gene expression in filamentous fungi", in:
More Gene Manipulations in Fungi, J.W. Bennet & L.L. Lasure, Ed., pp. 396-428: Academic Press: San Diego; and van
den Hondel, C.A.M.J.J., & Punt, P.J. (1991) "Gene transfer systems and vector development for filamentous fungi, in:
Applied Molecular Genetics of Fungi, Peberdy, J.F., et al., Ed., pp. 1-28, Cambridge University Press: Cambridge), algae
(Falciatore et al., 1999, Marine Biotechnology. 1, 3:239-251), ciliates of the types: Holotrichia, Peritrichia, Spirotrichia,
Suctoria, Tetrahymena, Paramecium, Colpidium, Glaucoma, Platyophrya, Potomacus, Desaturaseudocohnilembus, Eu-
plotes, Engelmaniella and Stylonychia, in particular of the genus Stylonychia lemnae, using vectors in a transformation
method as described in WO 98/01572 and, preferably, in cells of multi-celled plants (see Schmidt, R. and Willmitzer, L.
(1988) "High efficiency Agrobacterium tumefaciens-mediated transformation of Arabidopsis thaliana leaf and cotyledon
explants" Plant Cell Rep.:583-586; Plant Molecular Biology and Biotechnology, C Press, Boca Raton, Florida, Chapter
6/7, pp.71-119 (1993); F.F. White, B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering
and Utilization, Ed.: Kung and R. Wu, Academic Press (1993), 128-43; Potrykus, Annu. Rev. Plant Physiol. Plant Molec.
Biol. 42 (1991), 205-225 (and references cited therein)). Suitable host cells are furthermore discussed in Goeddel, Gene
Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, CA (1990). As an alternative, the
recombinant expression vector can be transcribed and translated in vitro, for example using T7-promoter regulatory
sequences and T7-polymerase.
[0071] In most cases, the expression of proteins in prokaryotes involves the use of vectors comprising constitutive or
inducible promoters which govern the expression of fusion or nonfusion proteins. Typical fusion expression vectors are,
inter alia, pGEX (Pharmacia Biotech Inc; Smith, D.B., and Johnson, K.S. (1988) Gene 67:31-40), pMAL (New England
Biolabs, Beverly, MA) und pRIT5 (Pharmacia, Piscataway, NJ), where glutathione S-transferase (GST), maltose-E
binding protein and protein A, respectively, is fused with the recombinant target protein.
[0072] Examples of suitable inducible nonfusion E. coli expression vectors are, inter alia, pTrc (Amann et al. (1988)
Gene 69:301-315) and pET 11 d (Studier et al., Gene Expression Technology: Methods in Enzymology 185, Academic
Press, San Diego, California (1990) 60-89). The target gene expression from the pTrc vector is based on the transcription
from a hybrid trp-lac fusion promoter by the host RNA polymerase. The target gene expression from the vector pET 11d
is based on the transcription of a T7-gn10-lac fusion promoter, which is mediated by a viral RNA polymerase (T7 gn1),
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which is coexpressed. This viral polymerase is provided by the host strains BL21 (DE3) or HMS174 (DE3) from a resident
λ-prophage which harbors a T7 gn1 gene under the transcriptional control of the lacUV 5 promoter.
[0073] Other vectors which are suitable for prokaryotic organisms are known to the skilled worker, these vectors are,
for example in E. coli pLG338, pACYC184, the pBR series such as pBR322, the pUC series such as pUC18 or pUC19,
the M113mp series, pKC30, pRep4, pHS1, pHS2, pPLc236, pMBL24, pLG200, pUR290, pIN-III113-B1, λgt11 or pBdCl,
in Streptomyces pIJ101, pIJ364, pIJ702 or pIJ361, in Bacillus pUB110, pC194 or pBD214, in Corynebacterium pSA77
or pAJ667.
[0074] In a further embodiment, the expression vector is a yeast expression vector. Examples for vectors for expression
in the yeast S.cerevisiae comprise pYeDesaturasec1 (Baldari et al. (1987) Embo J. 6:229-234), pMFa (Kurjan and
Herskowitz (1982) Cell 30:933-943), pJRY88 (Schultz et al. (1987) Gene 54:113-123) and pYES2 (Invitrogen Corporation,
San Diego, CA). Vectors and processes for the construction of vectors which are suitable for use in other fungi, such
as the filamentous fungi, comprise those which are described in detail in: van den Hondel, C.A.M.J.J., & Punt, P.J. (1991)
"Gene transfer systems and vector development for filamentous fungi, in: Applied Molecular Genetics of fungi, J.F.
Peberdy et al., Ed., pp. 1-28, Cambridge University Press: Cambridge, or in: More Gene Manipulations in Fungi [J.W.
Bennet & L.L. Lasure, Ed., pp. 396-428: Academic Press: San Diego]. Further suitable yeast vectors are, for example,
pAG-1, YEp6, YEp13 or pEMBLYe23.
[0075] As an alternative, ∆9-elongase, ∆8-desaturase and/or ∆5-desaturase can be expressed in insect cells using
Baculovirus vectors. Baculovirus expression vectors which are available for the expression of proteins in cultured insect
cells (for example Sf9 cells) comprise the pAc series (Smith et al. (1983) Mol. Cell Biol.. 3:2156-2165) and the pVL series
(Lucklow and Summers (1989) Virology 170:31-39).
[0076] The abovementioned vectors are only a small overview over suitable vectors which are possible. Further
plasmids are known to the skilled worker and are described, for example, in: Cloning Vectors (Ed. Pouwels, P.H., et al.,
Elsevier, Amsterdam-New York-Oxford, 1985, ISBN 0 444 904018). For further suitable expression systems for prokary-
otic and eukaryotic cells, see the Chapters 16 and 17 in Sambrook, J., Fritsch, E.F., and Maniatis, T., Molecular Cloning:
A Laboratory Manual, 2. edition, Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring
Harbor, NY, 1989.
[0077] In a further embodiment of the process, the ∆9-elongase, ∆8-desaturase and/or ∆5-desaturase can be ex-
pressed in single-celled plant cells (such as algae), see Falciatore et al., 1999, Marine Biotechnology 1 (3):239-251 and
references cited therein, and in plant cells from higher plants (for example spermatophytes such as arable crops).
Examples of plant expression vectors comprise those which are described in detail in: Becker, D., Kemper, E., Schell,
J., and Masterson, R. (1992) "New plant binary vectors with selectable markers located proximal to the left border", Plant
Mol. Biol. 20:1195-1197; and Bevan, M.W. (1984) "Binary Agrobacterium vectors for plant transformation", Nucl. Acids
Res. 12:8711-8721; Vectors for Gene Transfer in Higher Plants; in: Transgenic Plants, Vol. 1, Engineering and Utilization,
Ed.: Kung and R. Wu, Academic Press, 1993, p. 15-38.
[0078] A plant expression cassette preferably comprises regulatory sequences which are capable of governing the
expression of genes in plant cells and which are linked operably so that each sequence can fulfill its function, such as
transcriptional termination, for example polyadenylation signals. Preferred polyadenylation signals are those which are
derived from Agrobacterium tumefaciens T-DNA, such as gene 3 of the Ti plasmid pTiACH5 (Gielen et al., EMBO J. 3
(1984) 835 et seq.), which is known as octopine synthase, or functional equivalents thereof, but all other terminator
sequences which are functionally active in plants are also suitable.
[0079] Since plant gene expression is very often not limited to the transcriptional level, a plant expression cassette
preferably comprises other sequences which are linked operably, such as translation enhancers, for example the over-
drive sequence, which enhances the tobacco mosaic virus 5’- untranslated leader sequence, which increases the pro-
tein/RNA ratio (Gallie et al., 1987, Nucl. Acids Research 15:8693-8711).
[0080] As described above, plant gene expression must be linked operably with a suitable promoter which triggers
gene expression with the correct timing or in a cell- or tissue-specific manner. Utilizable promoters are constitutive
promoters (Benfey et al., EMBO J. 8 (1989) 2195-2202), such as those which are derived from plant viruses, such as
35S CaMV (Franck et al., Cell 21 (1980) 285-294), 19S CaMV (see also US 5352605 and WO 84/02913), or plant
promoters, such as the promoter of the Rubisco subunit, which is described in US 4,962,028.
[0081] Other preferred sequences for use in operable linkage in plant gene expression cassettes are targeting se-
quences, which are required for steering the gene product into its corresponding cell compartment (see a review in
Kermode, Crit. Rev. Plant Sci. 15, 4 (1996) 285-423 and references cited therein), for example into the vacuole, into the
nucleus, all types of plastids, such as amyloplasts, chloroplasts, chromoplasts, the extracellular space, the mitochondria,
the endoplasmid reticulum, elaioplasts, peroxisomes and other compartments of plant cells.
[0082] As described above, plant gene expression can also be achieved via a chemically inducible promoter (see
review in Gatz 1997, Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108). Chemically inducible promoters are partic-
ularly suitable when it is desired that the gene expression takes place in a time-specific manner. Examples of such
promoters are a salicylic-acid-inducible promoter (WO 95/19443), a tetracyclin-inducible promoter (Gatz et al. (1992)
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Plant J. 2, 397-404) and an ethanol-inducible promoter.
[0083] Promoters which respond to biotic or abiotic stress conditions are also suitable, for example the pathogen-
induced PRP1 gene promoter (Ward et al., Plant. Mol. Biol. 22 (1993) 361-366), the heat-inducible tomato hsp80 promoter
(US 5,187,267), the chill-inducible potato alpha-amylase promoter (WO 96/12814) or the wound-inducible pinII promoter
(EP-A-0 375 091).
[0084] Especially preferred are those promoters which bring about the gene expression in tissues and organs in which
the biosynthesis of fatty acids, lipids and oils takes place, in seed cells, such as cells of the endosperm and of the
developing embryo. Suitable promoters are the oilseed rape napin promoter (US 5,608,152), the Vicia faba USP promoter
(Baeumlein et al., Mol Gen Genet, 1991, 225 (3):459-67), the Arabidopsis oleosin promoter (WO 98/45461), the Phaseolus
vulgaris phaseolin promoter (US 5,504,200), the Brassica Bce4 promoter (WO 91/13980) or the legumine B4 promoter
(LeB4; Baeumlein et al., 1992, Plant Journal, 2 (2):233-9), and promoters which bring about the seed-specific expression
in monocotyledonous plants such as maize, barley, wheat, rye, rice and the like. Suitable noteworthy promoters are the
barley lpt2 or lpt1 gene promoter (WO 95/15389 and WO 95/23230) or the promoters from the barley hordein gene, the
rice glutelin gene, the rice oryzin gene, the rice prolamine gene, the wheat gliadine gene, the wheat glutelin gene, the
maize zeine gene, the oat glutelin gene, the sorghum kasirin gene or the rye secalin gene, which are described in WO
99/16890.
[0085] As described above, it may be advantageous to include in an expression cassette nucleic acid encoding
enzymes capable of coverting ARA to ω3-unsaturated fatty acids such as EPA or DHA. Thus, for example the expression
cassette may also include nucleic acid encoding a ∆5-elongase, ω3-desaturase and/or ∆4-desaturase. Such expression
cassettes can be introduced via the simultaneous transformation of a plurality of individual expression constructs or,
preferably, by combining a plurality of expression cassettes on one construct. Also, a plurality of vectors can be trans-
formed with in each case a plurality of expression cassettes and then transferred into the host cell.
[0086] Other promoters which are likewise especially suitable are those which bring about a plastid-specific expression,
since plastids constitute the compartment in which the precursors and some end products of lipid biosynthesis are
synthesized. Suitable promoters, such as the viral RNA polymerase promoter, are described in WO 95/16783 and WO
97/06250, and the clpP promoter from Arabidopsis, described in WO 99/46394.
[0087] Vector DNA can be introduced into prokaryotic and eukaryotic cells via conventional transformation or trans-
fection techniques. The terms "transformation" and "transfection", conjugation and transduction, as used in the present
context, are intended to comprise a multiplicity of methods known in the prior art for the introduction of foreign nucleic
acid (for example DNA) into a host cell, including calcium phosphate or calcium chloride coprecipitation, DEAE-dextran-
mediated transfection, lipofection, natural competence, chemically mediated transfer, electroporation or particle bom-
bardment. Suitable methods for the transformation or transfection of host cells, including plant cells, can be found in
Sambrook et al. (Molecular Cloning: A Laboratory Manual., 2nd ed., Cold Spring Harbor Laboratory, Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY, 1989) and other laboratory textbooks such as Methods in Molecular Biology,
1995, Vol. 44, Agrobacterium protocols, Ed.: Gartland and Davey, Humana Press, Totowa, New Jersey.
[0088] In a further aspect of the invention there is provided a transgenic non human organism comprising at least one
transgene comprising a nucleic acid according to a previous aspect of the invention, or comprising at least one gene
construct or vector according to a previous aspect of the invention.
[0089] The transgenic nonhuman organism may be a microorganism, a nonhuman animal or a plant.
[0090] Host cells which are suitable in principle for taking up the nucleic acid according to the invention, the gene
product according to the invention or the vector according to the invention are all prokaryotic or eukaryotic organisms.
The host organisms which are advantageously used are microorganisms such as fungi or yeasts, or plant cells, preferably
plants or parts thereof. Fungi, yeasts or plants are preferably used, especially plants, for example plants such as oil
crops, which are high in lipid compounds, such as oilseed rape, evening primrose, hemp, thistle, peanut, canola, linseed,
soybean, safflower, sunflower, borage, or plants such as maize, wheat, rye, oats, triticale, rice, barley, cotton, cassava,
pepper, Tagetes, Solanacea plants such as potato, tobacco, eggplant and tomato, Vicia species, pea, alfalfa, bushy
plants (coffee, cacao, tea), Salix species, trees (oil palm, coconut), and perennial grasses and fodder crops. Especially
preferred plants according to the invention are oil crops such as soybean, peanut, oilseed rape, canola, linseed, hemp,
evening primrose, sunflower, safflower, trees (oil palm, coconut).
[0091] In an advantageous embodiment, the term "nucleic acid (molecule)" as used in the present context additionally
comprises the untranslated sequence at the 3’ and at the 5’ end of the coding gene region: at least 500, preferably 200,
especially preferably 100 nucleotides of the sequence upstream of the 5’ end of the coding region and at least 100,
preferably 50, especially preferably 20 nucleotides of the sequence downstream of the 3’ end of the coding gene region.
An "isolated" nucleic acid molecule is separate from other nucleic acid molecules which are present in the natural source
of the nucleic acid. An "isolated" nucleic acid preferably has no sequences which naturally flank the nucleic acid in the
genomic DNA of the organism from which the nucleic acid is derived (for example sequences which are located at the
5’ and 3’ ends of the nucleic acid). In various embodiments, the isolated ∆9-elongase, ∆B-desaturase or ∆5-desaturase
molecule can comprise for example fewer than approximately 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb or 0.1 kb of nucleotide
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sequences which naturally flank the nucleic acid molecule in the genomic DNA of the cell from which the nucleic acid
is derived. The same applies to other nucleic acid sequences which may be included in an expression cassette, for
example sequences encoding a ∆5-elongase, ω3-desaturase and/or ∆4-desaturase
[0092] The nucleic acid molecules of the present invention
can be isolated using molecular-biological standard techniques and the sequence information provided herein. Also, for
example a homologous sequence or homologous, conserved sequence regions can be identified at the DNA or amino
acid level with the aid of comparative algorithms. They can be used as hybridization probe and standard hybridization
techniques (such as, for example, those described in Sambrook et al., Molecular Cloning: A Laboratory Manual. 2nd
ed., Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989) for isolating
further nucleic acid sequences which can be used in the process.
[0093] Moreover, a nucleic acid molecule from Perkinsus marinus comprising a complete sequence of SEQ ID NO:
1 or a part thereof can be isolated by polymerase chain reaction, where oligonucleotide primers which are used on the
basis of this sequence or parts thereof (for example a nucleic acid molecule comprising the complete sequence or part
thereof can be isolated by polymerase chain reaction using oligonucleotide primers which have been generated based
on this same sequence). For example, mRNA can be isolated from cells (for example by means of the guanidinium
thiocyanate extraction method of Chirgwin et al. (1979) Biochemistry 18:5294-5299) and cDNA by means of reverse
transcriptase (for example Moloney MLV reverse transcriptase, available from Gibco/BRL, Bethesda, MD, or AMV
reverse transcriptase, available from Seikagaku America, Inc., St.Petersburg, FL).
[0094] Synthetic oligonucleotide primers for the amplification by means of polymerase chain reaction can be generated
based on one of the sequences shown in SEQ ID NO: 1 or with the aid of the amino acid sequences detailed in SEQ
ID NO: 2, SEQ ID NO: 3 and SEQ ID NO: 4. Particularly suitable primers are shown in the Examples as SEQ ID NO: 5
and SEQ ID NO: 6.
[0095] A nucleic acid according to the invention can be amplified by standard PCR amplification techniques using
cDNA or, alternatively, genomic DNA as template (SEQ ID NO 9) and suitable oligonucleotide primers (SEQ ID NO: 5
and SEQ ID NO: 6). The nucleic acid amplified thus can be cloned into a suitable vector and characterized by means
of DNA sequence analysis. Oligonucleotides which correspond to a desaturase or elongase nucleotide sequence can
be generated by standard synthetic methods, for example using an automatic DNA synthesizer.
[0096] The abovementioned nucleic acids and protein molecules with ∆9-elongase, ∆8-desaturase and/or ∆5-desat-
urase activity may be used in a process for the production of ARA from linoleic acid in transgenic organisms.
[0097] There is described a process for the conversion of linoleic acid or a derivative thereof to arachidonic acid or a
derivative thereof in an organism, the process comprising introducing into an organism which comprises linoleic acid at
least one nucleic acid sequence comprising :
a) SEQ ID NO: 1 (Full sequence 1047306867), sequence comprising nucleic acid residues 7668 to 12077 of SEQ
ID NO: 1 or a homolog of one of these;
b) nucleic acid sequences which hybridize under stringent conditions with a nucleic acid sequence of SEQ ID NO:
1 or a sequence comprising nucleic acid residues 7668 to 12077 of SEQ ID NO: 1;
c) an isolated nucleic acid sequence which encodes polypeptides with ∆9-elongase, ∆8-desaturase and ∆5-desat-
urase activity, wherein the polypeptides are selected from the group consisting of SEQ ID NOS 2, 3 and 4;
d) A derivative of a nucleic acid sequence of SEQ ID NO: 1 which encodes polypeptides with at least 40% identity
at the amino acid level with SEQ ID NO: 2, SEQ ID NO: 3 and SEQ ID NO: 4; wherein said polypeptides have ∆9-
elongase, ∆8-desaturase and ∆5-desaturase activity.
and expressing said nucleic acid sequence.
[0098] In the context of the present invention, a "derivative" of linoleic or arachidonic acid is a compound in which the
OH of the carboxylic acid moiety is replaced by a moiety R1, wherein:
R1 is coenzyme A (thioester), lysophosphatidylcholine, lysophosphatidylethanolamine, lysophosphatidylglycerol,
lyso- diphosphatidylglycerol, lysophosphatidylserine, lysophosphatidylinositol, sphingo base or a radical of the
formula II
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in which
R2 = hydrogen, lysophosphatidyl choline, lysophosphatidylethanolamine, lysophosphatidylglycerol, lysodiphosphati-
dylglycerol, lysophosphatidylserine, lysophosphatidylinositol or saturated or unsaturated C2-C24-alkylcarbonyl,
R3 = hydrogen, saturated or unsaturated C2-C24-alkylcarbonyl, or R2 and R3 independently of one another are a
radical of the formula Ia:
in which n = 2, 3, 4, 5, 6, 7 or 9, m = 2, 3, 4, 5 or 6 and p = 0 or 3;
and wherein an oxygen in the R1 radical may be replaced by sulphur such that R1 is bonded to the remainder
of the molecule via a thioester linkage.
[0099] The processes preferably yields total ARA in a content of at least 1% by weight, advantageously at least 3%
by weight, based on the total fatty acids in the transgenic organisms, preferably in a transgenic plant.
[0100] Since a plurality of reaction steps are performed by the starting compounds linoleic acid (18:2∆9,12) in the
process ARA (20:4∆5,8,11,14) is not obtained as a pure product; minor traces of the precursors are always present in the
end product.
[0101] Chemically pure ARA can also be synthesized by the process described above. To this end, ARA or a derivative
thereof is isolated from the organisms, such as the microorganisms or the plants or the culture medium in or on which
the organisms have been grown, or from the organism and the culture medium, in the known manner, for example via
extraction, distillation, crystallization, chromatography or a combination of these methods. These chemically ARA or
ARA derivatives are advantageous for applications in the food industry sector, the cosmetic sector and especially the
pharmacological industry sector.
[0102] The process may include additional steps of converting the ARA to an ω-3 fatty acid by introducing into the
organism nucleic acid encoding a ω-3 desaturase and optionally a ∆5-elongase and/or a ∆4-elongase and/or a ∆4-
desaturase.
[0103] In a further aspect the invention there is provided a process for the convention of 18:2∆9,12 (linoleic acid) to 20:
2∆11,14, the process comprising introducing into an organism which comprises linoleic acid at least one nucleic acid
molecule which encodes a polypeptide having ∆9-elongase activity and which comprise:
a) a sequence comprising nucleic acid residues 7668 to 9200 of SEQ ID NO: 1, SEQ ID NO: 9 or a homolog of one
of these:
b) an isolated nucleic acid sequence which encodes a polypeptide with ∆9-elongase activity, wherein the polypeptide
comprises SEQ ID NO: 2 or SEQ ID NO: 10;
c) A derivative of a a sequence comprising nucleic acid residues 7668 to 9200 of SEQ ID NO: 1 or SEQ ID NO: 9
which encodes a polypeptide with at least 40% identity at the amino acid level with SEQ ID NO: 2 or SEQ ID NO:
10; wherein said polypeptide has ∆9-elongase activity;
and expressing said nucleic acid sequence.
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[0104] The process may include additional steps of converting the ARA to an ω-3 fatty acid by introducing into the
organism nucleic acid encoding a ω-3 desaturase and optionally a ∆5-elongase and/or a ∆4-elongase and/or a ∆4-
desaturase.
[0105] For the processes set out above, it has been found that expression has been most effectively achieved using
induction with galactose.
[0106] Suitable organisms for the production in the process according to the invention are, in principle, any organisms
such as microorganisms, nonhuman animals or plants.
[0107] Plants which are suitable are, in principle, all those plants which are capable of synthesizing fatty acids, such
as all dicotyledonous or monocotyledonous plants, algae or mosses. Advantageous plants are selected from the group
of the plant families Adelotheciaceae, Anacardiaceae, Asteraceae, Apiaceae, Betulaceae, Boraginaceae, Brassicaceae,
Bromeliaceae, Caricaceae, Cannabaceae, Convolvulaceae, Chenopodiaceae, Crypthecodiniaceae, Cucurbitaceae,
Ditrichaceae, Elaeagnaceae, Ericaceae, Euphorbiaceae, Fabaceae, Geraniaceae, Gramineae, Juglandaceae, Laurace-
ae, Leguminosae, Linaceae, Euglenaceae, Prasinophyceae or vegetable plants or ornamentals such as Tagetes.
[0108] Examples which may be mentioned are the following plants selected from the group consisting of: Adelothe-
ciaceae such as the genera Physcomitrella, for example the genus and species Physcomitrella patens, Anacardiaceae
such as the genera Pistacia, Mangifera, Anacardium, for example the genus and species Pistacia vera [pistachio],
Mangifer indica [mango] or Anacardium occidentale [cashew], Asteraceae, such as the genera Calendula, Carthamus,
Centaurea, Cichorium, Cynara, Helianthus, Lactuca, Locusta, Tagetes, Valeriana, for example the genus and species
Calendula officinalis [common marigold], Carthamus tinctorius [safflower], Centaurea cyanus [cornflower], Cichorium
intybus [chicory], Cynara scolymus [artichoke], Helianthus annus [sunflower], Lactuca sativa, Lactuca crispa, Lactuca
esculenta, Lactuca scariola L. ssp. sativa, Lactuca scariola L. var. integrata, Lactuca scariola L. var. integrifolia, Lactuca
sativa subsp. romana, Locusta communis, Valeriana locusta [salad vegetables], Tagetes lucida, Tagetes erecta or
Tagetes tenuifolia [african or french marigold], Apiaceae, such as the genus Daucus, for example the genus and species
Daucus carota [carrot], Betulaceae, such as the genus Corylus, for example the genera and species Corylus avellana
or Corylus colurna [hazelnut], Boraginaceae, such as the genus Borago, for example the genus and species Borago
officinalis [borage], Brassicaceae, such as the genera Brassica, Camelina, Melanosinapis, Sinapis, Arabadopsis, for
example the genera and species Brassica napus, Brassica rapa ssp. [oilseed rape], Sinapis arvensis Brassica juncea,
Brassica juncea var. juncea, Brassica juncea var. crispifolia, Brassica juncea var. foliosa, Brassica nigra, Brassica
sinapioides, Camelina sativa, Melanosinapis communis [mustard], Brassica oleracea [fodder beet] or Arabidopsis thal-
iana, Bromeliaceae, such as the genera Anana, Bromelia (pineapple), for example the genera and species Anana
comosus, Ananas ananas or Bromelia comosa [pineapple], Caricaceae, such as the genus Carica, such as the genus
and species Carica papaya [pawpaw], Cannabaceae, such as the genus Cannabis, such as the genus and species
Cannabis sativa [hemp], Convolvulaceae, such as the genera Ipomea, Convolvulus, for example the genera and species
Ipomoea batatus, Ipomoea pandurata, Convolvulus batatas, Convolvulus tiliaceus, Ipomoea fastigiata, Ipomoea tiliacea,
Ipomoea triloba or Convolvulus panduratus [sweet potato, batate], Chenopodiaceae, such as the genus Beta, such as
the genera and species Beta vulgaris, Beta vulgaris var. altissima, Beta vulgaris var. vulgaris, Beta maritima, Beta
vulgaris var. perennis, Beta vulgaris var. conditiva or Beta vulgaris var esculenta [sugarbeet], Crypthecodiniaceae, such
as the genus Crypthecodinium, for example the genus and species Cryptecodinium cohnii, Cucurbitaceae, such as the
genus Cucurbita, for example the genera and species Cucurbita maxima, Cucurbita mixta, Cucurbita pepo or Cucurbita
moschata [pumpkin/squash], Cymbellaceae, such as the genera Amphora, Cymbella, Okedenia, Phaeodactylum, Re-
imeria, for example the genus and species Phaeodactylum tricornutum, Ditrichaceae, such as the genera Ditrichaceae,
Astomiopsis, Ceratodon, Chrysoblastella, Ditrichum, Distichium, Eccremidium, Lophidion, Philibertiella, Pleuridium, Sae-
lania, Trichodon, Skottsbergia, for example the genera and species Ceratodon antarcticus, Ceratodon columbiae, Cer-
atodon heterophyllus, Ceratodon purpurascens, Ceratodon purpureus, Ceratodon purpureus ssp. convolutus, Cera-
todon purpureus ssp. stenocarpus, Ceratodon purpureus var. rotundifolius, Ceratodon ratodon, Ceratodon stenocarpus,
Chrysoblastella chilensis, Ditrichum ambiguum, Ditrichum brevisetum, Ditrichum crispatissimum, Ditrichum difficile,
Ditrichum falcifolium, Ditrichum flexicaule, Ditrichum giganteum, Ditrichum heteromallum, Ditrichum lineare, Ditrichum
lineare, Ditrichum montanum, Ditrichum montanum, Ditrichum pallidum, Ditrichum punctulatum, Ditrichum pusillum,
Ditrichum pusillum var. tortile, Ditrichum rhynchostegium, Ditrichum schimperi, Ditrichum tortile, Distichium capillaceum,
Distichium hagenii, Distichium inclinatum, Distichium macounii, Eccremidium floridanum, Eccremidium whiteleggei,
Lophidion strictus, Pleuridium acuminatum, Pleuridium alternifolium, Pleuridium holdridgei, Pleuridium mexicanum,
Pleuridium ravenelii, Pleuridium subulatum, Saelania glaucescens, Trichodon borealis, Trichodon cylindricus or Tri-
chodon cylindricus var. oblongus, Elaeagnaceae, such as the genus Elaeagnus, for example the genus and species
Olea europaea [olive], Ericaceae, such as the genus Kalmia, for example the genera and species Kalmia latifolia, Kalmia
angustifolia, Kalmia microphylla, Kalmia polifolia, Kalmia occidentalis, Cistus chamaerhodendros or Kalmia lucida
[mountain laurel], Euglenaceae, such as the genera Ascoglena, Astasia, Colacium, Cyclidiopsis, Euglena, Euglenopsis,
Hyalaphacus, Khawkinea, Lepocinclis, Phacus, Strombomonas, Trachelomonas, for example the genus and species
Euglena gracilis; Euphorbiaceae, such as the genera Manihot, Janipha, Jatropha, Ricinus, for example the genera and
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species Manihot utilissima, Janipha manihot, Jatropha manihot, Manihot aipil, Manihot dulcis, Manihot manihot, Manihot
melanobasis, Manihot esculenta [cassava] or Ricinus communis [castor-oil plant], Fabaceae, such as the genera Pisum,
Albizia, Cathormion, Feuillea, Inga, Pithecolobium, Acacia, Mimosa, Medicajo, Glycine, Dolichos, Phaseolus, soybean,
for example the genera and species Pisum sativum, Pisum arvense, Pisum humile [pea], Albizia berteriana, Albizia
julibrissin, Albizia lebbeck, Acacia berteriana, Acacia littoralis, Albizia berteriana, Albizzia berteriana, Cathormion ber-
teriana, Feuillea berteriana, Inga fragrans, Pithecellobium berterianum, Pithecellobium fragrans, Pithecolobium bert-
erianum, Pseudalbizzia berteriana, Acacia julibrissin, Acacia nemu, Albizia nemu, Feuilleea julibrissin, Mimosa julibris-
sin, Mimosa speciosa, Sericanrda julibrissin, Acacia lebbeck, Acacia macrophylla, Albizia lebbeck, Feuilleea lebbeck,
Mimosa lebbeck, Mimosa speciosa, Medicago sativa, Medicago falcata, Medicago varia [alfalfa] Glycine max Dolichos
soja, Glycine gracilis, Glycine hispida, Phaseolus max, Soja hispida or Soja max [soybean], Funariaceae, such as the
genera Aphanorrhegma, Entosthodon, Funaria, Physcomitrella, Physcomitrium, for example the genera and species
Aphanorrhegma serratum, Entosthodon attenuatus, Entosthodon bolanderi, Entosthodon bonplandii, Entosthodon cal-
ifornicus, Entosthodon drummondii, Entosthodon jamesonii, Entosthodon leibergii, Entosthodon neoscoticus, Ento-
sthodon rubrisetus, Entosthodon spathulifolius, Entosthodon tucsoni, Funaria americana, Funaria bolanderi, Funaria
calcarea, Funaria californica, Funaria calvescens, Funaria convoluta, Funaria flavicans, Funaria groutiana, Funaria
hygrometrica, Funaria hygrometrica var. arctica, Funaria hygrometrica var. calvescens, Funaria hygrometrica var.
convoluta, Funaria hygrometrica var. muralis, Funaria hygrometrica var. utahensis, Funaria microstoma, Funaria micro-
stoma var. obtusifolia, Funaria muhlenbergii, Funaria orcuttii, Funaria plano-convexa, Funaria polaris, Funaria ravenelii,
Funaria rubriseta, Funaria serrata, Funaria sonorae, Funaria sublimbatus, Funaria tucsoni, Physcomitrella californica,
Physcomitrella patens, Physcomitrella readeri, Physcomitrium australe, Physcomitrium californicum, Physcomitrium
collenchymatum, Physcomitrium coloradense, Physcomitrium cupuliferum, Physcomitrium drummondii, Physcomitrium
eurystomum, Physcomitrium flexifolium, Physcomitrium hookeri, Physcomitrium hookeri var. serratum, Physcomitrium
immersum, Physcomitrium kellermanii, Physcomitrium megalocarpum, Physcomitrium pyriforme, Physcomitrium pyri-
forme var. serratum, Physcomitrium rufipes, Physcomitrium sandbergii, Physcomitrium subsphaericum, Physcomitrium
washingtoniense, Geraniaceae; such as the genera Pelargonium, Cocos, Oleum, for example the genera and species
Cocos nucifera, Pelargonium grossularioides or Oleum cocois [coconut], Gramineae, such as the genus Saccharum,
for example the genus and species Saccharum officinarum, Juglandaceae, such as the genera Juglans, Wallia, for.ex-
ample the genera and species Juglans regia, Juglans ailanthifolia, Juglans sieboldiana, Juglans cinerea, Wallia cinerea,
Juglans bixbyi, Juglans californica, Juglans hindsii, Juglans intermedia, Juglans jamaicensis, Juglans major, Juglans
microcarpa, Juglans nigra or Wallia nigra [walnut], Lauraceae, such as the genera Persea, Laurus, for example the
genera and species Laurus nobilis [bay], Persea americana, Persea gratissima or Persea persea [avocado], Legumi-
nosae, such as the genus Arachis, for example the genus and species Arachis hypogaea [peanut], Linaceae, such as
the genera Adenolinum, for example the genera and species Linum usitatissimum, Linum humile, Linum austriacum,
Linum bienne, Linum angustifolium, Linum catharticum, Linum flavum, Linum grandiflorum, Adenolinum grandiflorum,
Linum lewisii, Linum narbonense, Linum perenne, Linum perenne var. lewisii, Linum pratense or Linum trigynum
[linseed], Lythrarieae, such as the genus Punica, for example the genus and species Punica granatum [pomegranate],
Malvaceae, such as the genus Gossypium, for example the genera and species Gossypium hirsutum, Gossypium
arboreum, Gossypium barbadense, Gossypium herbaceum or Gossypium thurberi [cotton], Marchantiaceae, such as
the genus Marchantia, for example the genera and species Marchantia berteroana, Marchantia foliacea, Marchantia
macropora, Musaceae, such as the genus Musa, for example the genera and species Musa nana, Musa acuminata,
Musa paradisiaca, Musa spp. [banana], Onagraceae, such as the genera Camissonia, Oenothera, for example the
genera and species Oenothera biennis or Camissonia brevipes [evening primrose], Palmae, such as the genus Elaeis,
for example the genus and species Elaeis guineensis [oil palm], Papaveraceae, such as, for example, the genus Papaver,
for example the genera and species Papaver orientale, Papaver rhoeas, Papaver dubium [poppy], Pedaliaceae, such
as the genus Sesamum, for example the genus and species Sesamum indicum [sesame], Piperaceae, such as the
genera Piper, Artanthe, Peperomia, Steffensia, for example the genera and species Piper aduncum, Piper amalago,
Piper angustifolium, Piper auritum, Piper betel, Piper cubeba, Piper longum, Piper nigrum, Piper retrofractum, Artanthe
adunca, Artanthe elongata, Peperomia elongata, Piper elongatum, Steffensia elongata [cayenne pepper], Poaceae,
such as the genera Hordeum, Secale, Avena, Sorghum, Andropogon, Holcus, Panicum, Oryza, Zea (maize), Triticum,
for example the genera and species Hordeum vulgare, Hordeum jubatum, Hordeum murinum, Hordeum secalinum,
Hordeum distichon Hordeum aegiceras, Hordeum hexastichon, Hordeum hexastichum, Hordeum irregulare, Hordeum
sativum, Hordeum secalinum [barley], Secale cereale [rye], Avena sativa, Avena fatua, Avena byzantina, Avena fatua
var. sativa, Avena hybrida [oats], Sorghum bicolor, Sorghum halepense, Sorghum saccharatum, Sorghum vulgare,
Andropogon drummondii, Holcus bicolor, Holcus sorghum, Sorghum aethiopicum, Sorghum arundinaceum, Sorghum
caffrorum, Sorghum cernuum, Sorghum dochna, Sorghum drummondii, Sorghum durra, Sorghum guineense, Sorghum
lanceolatum, Sorghum nervosum, Sorghum saccharatum, Sorghum subglabrescens, Sorghum verticilliflorum, Sorghum
vulgare, Holcus halepensis, Sorghum miliaceum, Panicum militaceum [millet], Oryza sativa, Oryza latifolia [rice], Zea
mays [maize] Triticum aestivum, Triticum durum, Triticum turgidum, Triticum hybernum, Triticum macha, Triticum sati-
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vum or Triticum vulgare [wheat], Porphyridiaceae, such as the genera Chroothece, Flintiella, Petrovanella, Porphyridium,
Rhodella, Rhodosorus, Vanhoeffenia, for example the genus and species Porphyridium cruentum, Proteaceae, such
as the genus Macadamia, for example the genus and species Macadamia intergrifolia [macadamia], Prasinophyceae,
such as the genera Nephroselmis, Prasinococcus, Scherffelia, Tetraselmis, Mantoniella, Ostreococcus, for example the
genera and species Nephroselmis olivacea, Prasinococcus capsulatus, Scherffelia dubia, Tetraselmis chui, Tetraselmis
suecica, Mantoniella squamata, Ostreococcus tauri, Rubiaceae, such as the genus Coffea, for example the genera and
species Coffea spp., Coffea arabica, Coffea canephora or Coffea liberica [coffee], Scrophulariaceae, such as the genus
Verbascum, for example the genera and species Verbascum blattaria, Verbascum chaixii, Verbascum densiflorum,
Verbascum lagurus, Verbascum longifolium, Verbascum lychnitis, Verbascum nigrum, Verbascum olympicum, Ver-
bascum phlomoides, Verbascum phoenicum, Verbascum pulverulentum or Verbascum thapsus [verbascum], Solanace-
ae, such as the genera Capsicum, Nicotiana, Solanum, Lycopersicon, for example the genera and species Capsicum
annuum, Capsicum annuum var. glabriusculum, Capsicum frutescens [pepper], Capsicum annuum [paprika], Nicotiana
tabacum, Nicotiana alata, Nicotiana attenuata, Nicotiana glauca, Nicotiana langsdorlfii, Nicotiana obtusifolia, Nicotiana
quadrivalvis, Nicotiana repanda, Nicotiana rustica, Nicotiana sylvestris [tobacco], Solanum tuberosum [potato], Solanum
melongena [eggplant] Lycopersicon esculentum, Lycopersicon lycopersicum, Lycopersicon pyriforme, Solanum integri-
folium or Solanum lycopersicum [tomato], Sterculiaceae, such as the genus Theobroma, for example the genus and
species Theobroma cacao [cacao] or Theaceae, such as the genus Camellia, for example the genus and species
Camellia sinensis [tea].
[0109] Advantageous microorganisms are, for example, fungi selected from the group of the families Chaetomiaceae,
Choanephoraceae, Cryptococcaceae, Cunninghamellaceae, Demetiaceae, Moniliaceae, Mortierellaceae, Mucoraceae,
Pythiaceae, Sacharomycetaceae, Saprolegniaceae, Schizosacharomycetaceae, Sodariaceae or Tuberculariaceae.
[0110] Examples of microorganisms which may be mentioned are those from the groups: Choanephoraceae, such
as the genera Blakeslea, Choanephora, for example the genera and species Blakeslea trispora, Choanephora cucur-
bitarum, Choanephora infundibulifera var. cucurbitarum, Mortierellaceae, such as the genus Mortierella, for example
the genera and species Mortierella isabellina, Mortierella polycephala , Mortierella ramanniana , Mortierella vinacea,
Mortierella zonata, Pythiaceae, such as the genera Phytium, Phytophthora, for example the genera and species Pythium
debaryanum, Pythium intermedium, Pythium irregulare, Pythium megalacanthum, Pythium paroecandrum, Pythium
sylvaticum, Pythium ultimum, Phytophthora cactorum, Phytophthora cinnamomi, Phytophthora citricola, Phytophthora
citrophthora, Phytophthora cryptogea, Phytophthora drechsleri, Phytophthora erythroseptica, Phytophthora lateralis,
Phytophthora megasperma, Phytophthora nicotianae, Phytophthora nicotianae var. parasitica, Phytophthora palmivora,
Phytophthora parasitica, Phytophthora syringae, Saccharomycetaceae, such as the genera Hansenula, Pichia, Sac-
charomyces, Saccharomycodes, Yarrowia, for example the genera and species Hansenula anomala, Hansenula cali-
fornica, Hansenula canadensis, Hansenula capsulata, Hansenula ciferrii, Hansenula glucozyma, Hansenula henricii,
Hansenula holstii, Hansenula minuta, Hansenula nonfermentans, Hansenula philodendri, Hansenula polymorpha,
Hansenula saturnus, Hansenula subpelliculosa, Hansenula wickerhamii, Hansenula wingei, Pichia alcoholophila, Pichia
angusta, Pichia anomala, Pichia bispora, Pichia burtonii, Pichia canadensis, Pichia capsulata, Pichia carsonii, Pichia
cellobiosa, Pichia ciferrii, Pichia farinosa, Pichia fermentans, Pichia finlandica, Pichia glucozyma, Pichia guilliermondii,
Pichia haplophila, Pichia henricii, Pichia holstii, Pichia jadinii, Pichia lindnerii, Pichia membranaefaciens, Pichia meth-
anolica, Pichia minuta var. minuta, Pichia minuta var. nonfermentans, Pichia norvegensis, Pichia ohmeri, Pichia pastoris,
Pichia philodendri, Pichia pini, Pichia polymorpha, Pichia quercuum, Pichia rhodanensis, Pichia sargentensis, Pichia
stipitis, Pichia strasburgensis, Pichia subpelliculosa, Pichia toletana, Pichia trehalophila, Pichia vini, Pichia xylosa,
Saccharomyces aceti, Saccharomyces bailii, Saccharomyces bayanus, Saccharomyces bisporus, Saccharomyces
capensis, Saccharomyces carlsbergensis, Saccharomyces cerevisiae, Saccharomyces cerevisiae var. ellipsoideus,
Saccharomyces chevalieri, Saccharomyces delbrueckii, Saccharomyces diastaticus, Saccharomyces drosophilarum,
Saccharomyces elegans, Saccharomyces ellipsoideus, Saccharomyces fermentati, Saccharomyces florentinus, Sac-
charomyces fragilis, Saccharomyces heterogenicus, Saccharomyces hienipiensis, Saccharomyces inusitatus, Sac-
charomyces italicus, Saccharomyces kluyveri, Saccharomyces krusei, Saccharomyces lactis, Saccharomyces marx-
ianus, Saccharomyces microellipsoides, Saccharomyces montanus, Saccharomyces norbensis, Saccharomyces
oleaceus, Saccharomyces paradoxus, Saccharomyces pastorianus, Saccharomyces pretoriensis, Saccharomyces ro-
sei, Saccharomyces rouxii, Saccharomyces uvarum, Saccharomycodes ludwigii, Yarrowia lipolytica, Schizosacharo-
mycetaceae such as the genera Schizosaccharomyces e.g. the species Schizosaccharomyces japonicus var. japonicus,
Schizosaccharomyces japonicus var. versatilis, Schizosaccharomyces malidevorans, Schizosaccharomyces octos-
porus, Schizosaccharomyces pombe var. malidevorans, Schizosaccharomyces pombe var. pombe, Thraustochytriace-
ae such as the genera Althornia, Aplanochytrium, Japonochytrium, Schizochytrium, Thraustochytrium e.g. the species
Schizochytrium aggregatum, Schizochytrium limacinum, Schizochytrium mangrovei, Schizochytrium minutum, Schizo-
chytrium octosporum, Thraustochytrium aggregatum, Thraustochytrium amoeboideum, Thraustochytrium antacticum,
Thraustochytrium arudimentale, Thraustochytrium aureum, Thraustochytrium benthicola, Thraustochytrium globosum,
Thraustochytrium indicum, Thraustochytrium kerguelense, Thraustochytrium kinnei, Thraustochytrium motivum,
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Thraustochytrium multirudimentale, Thraustochytrium pachydermum, Thraustochytrium proliferum, Thraustochytrium
roseum, Thraustochytrium rossii, Thraustochytrium striatum or Thraustochytrium visurgense.
[0111] Further advantageous microorganisms are, for example, bacteria selected from the group of the families Bacil-
laceae, Enterobacteriacae or Rhizobiaceae.
[0112] Examples which may be mentioned are the following microorganisms selected from the group consisting of:
Bacillaceae, such as the genus Bacillus, for example the genera and species Bacillus acidocaldarius, Bacillus acido-
terrestris, Bacillus alcalophilus, Bacillus amyloliquefaciens, Bacillus amylolyticus, Bacillus brevis, Bacillus cereus, Ba-
cillus circulans, Bacillus coagulans, Bacillus sphaericus subsp. fusiformis, Bacillus galactophilus, Bacillus globisporus,
Bacillus globisporus subsp. marinus, Bacillus halophilus, Bacillus lentimorbus, Bacillus lentus, Bacillus licheniformis,
Bacillus megaterium, Bacillus polymyxa, Bacillus psychrosaccharolyticus, Bacillus pumilus, Bacillus sphaericus, Ba-
cillus subtilis subsp. spizizenii, Bacillus subtilis subsp. subtilis or Bacillus thuringiensis; Enterobacteriacae such as the
genera Citrobacter, Edwardsiella, Enterobacter, Erwinia, Escherichia, Klebsiella, Salmonella or Serratia, for example
the genera and species Citrobacter amalonaticus, Citrobacter diversus, Citrobacter freundii, Citrobacter genomospe-
cies, Citrobacter gillenii, Citrobacter intermedium, Citrobacter koseri, Citrobacter murliniae, Citrobacter sp., Edwardsiella
hoshinae, Edwardsiella ictaluri, Edwardsiella tarda, Erwinia alni, Erwinia amylovora, Erwinia ananatis, Erwinia aphidi-
cola, Erwinia billingiae, Erwinia cacticida, Erwinia cancerogena, Erwinia carnegieana, Erwinia carotovora subsp.
atroseptica, Erwinia carotovora subsp. betavasculorum, Erwinia carotovora subsp. odorifera, Erwinia carotovora subsp.
wasabiae, Erwinia chrysanthemi, Erwinia cypripedii, Erwinia dissolvens, Erwinia herbicola, Erwinia mallotivora, Erwinia
milletiae, Erwinia nigrifluens, Erwinia nimipressuralis, Erwinia persicina, Erwinia psidii, Erwinia pyrifoliae, Erwinia querci-
na, Erwinia rhapontici, Erwinia rubrifaciens, Erwinia salicis, Erwinia stewartii, Erwinia tracheiphila, Erwinia uredovora,
Escherichia adecarboxylata, Escherichia anindolica, Escherichia aurescens, Escherichia blattae, Escherichia coli, Es-
cherichia coli var. communior, Escherichia coli-mutabile, Escherichia fergusonii, Escherichia hermannii, Escherichia
sp., Escherichia vulneris, Klebsiella aerogenes, Klebsiella edwardsii subsp. atlantae, Klebsiella ornithinolytica, Kleb-
siella oxytoca, Klebsiella planticola, Klebsiella pneumoniae, Klebsiella pneumoniae subsp. pneumoniae, Klebsiella sp.,
Klebsiella terrigena, Klebsiella trevisanii, Salmonella abony, Salmonella arizonae, Salmonella bongori, Salmonella
choleraesuis subsp. arizonae, Salmonella choleraesuis subsp. bongori, Salmonella choleraesuis subsp. cholereasuis,
Salmonella choleraesuis subsp. diarizonae, Salmonella choleraesuis subsp. houtenae, Salmonella choleraesuis subsp.
indica, Salmonella choleraesuis subsp. salamae, Salmonella daressalaam, Salmonella enterica subsp. houtenae, Sal-
monella enterica subsp. salamae, Salmonella enteritidis, Salmonella gallinarum, Salmonella heidelberg, Salmonella
panama, Salmonella senftenberg, Salmonella typhimurium, Serratia entomophila, Serratia ficaria, Serratia fonticola,
Serratia grimesii, Serratia liquefaciens, Serratia marcescens, Serratia marcescens subsp. marcescens, Serratia ma-
rinorubra, Serratia odorifera, Serratia plymouthensis, Serratia plymuthica, Serratia proteamaculans, Serratia pro-
teamaculans subsp. quinovora, Serratia quinivorans or Serratia rubidaea; Rhizobiaceae, such as the genera Agrobac-
terium, Carbophilus, Chelatobacter, Ensifer, Rhizobium, Sinorhizobium, for example the genera and species Agrobac-
terium atlanticum, Agrobacterium ferrugineum, Agrobacterium gelatinovorum, Agrobacterium larrymoorei, Agrobacte-
rium meteori, Agrobacterium radiobacter, Agrobacterium rhizogenes, Agrobacterium rubi, Agrobacterium stellulatum,
Agrobacterium tumefaciens, Agrobacterium vitis, Carbophilus carboxidus, Chelatobacter heintzii, Ensifer adhaerens,
Ensifer arboris, Ensifer fredii, Ensifer kostiensis, Ensifer kummerowiae, Ensifer medicae, Ensifer meliloti, Ensifer saheli,
Ensifer terangae, Ensifer xinjiangensis, Rhizobium ciceri Rhizobium etli, Rhizobium fredii, Rhizobium galegae, Rhizo-
bium gallicum, Rhizobium giardinii, Rhizobium hainanense, Rhizobium huakuii, Rhizobium huautlense, Rhizobium
indigoferae, Rhizobium japonicum, Rhizobium leguminosarum, Rhizobium loessense, Rhizobium loti, Rhizobium lupini,
Rhizobium mediterraneum, Rhizobium meliloti, Rhizobium mongolense, Rhizobium phaseoli, Rhizobium radiobacter,
Rhizobium rhizogenes, Rhizobium rubi, Rhizobium sullae, Rhizobium tianshanense, Rhizobium trifolii, Rhizobium tropi-
ci, Rhizobium undicola, Rhizobium vitis, Sinorhizobium adhaerens, Sinorhizobium arboris, Sinorhizobium fredii, Sinor-
hizobium kostiense, Sinorhizobium kummerowiae, Sinorhizobium medicae, Sinorhizobium meliloti, Sinorhizobium
morelense, Sinorhizobium saheli or Sinorhizobium xinjiangense.
[0113] Further examples of advantageous microorganisms for the process according to the invention are protists or
diatoms selected from the group of the families Dinophyceae, Turaniellidae or Oxytrichidae, such as the genera and
species: Crypthecodinium cohnii, Phaeodactylum tricornutum, Stylonychia mytilus, Stylonychia pustulata, Stylonychia
putrina, Stylonychia notophora, Stylonychia sp., Colpidium campylum or Colpidium sp.
[0114] Those which are advantageously applied in the process according to the invention are transgenic organisms
such as fungi, such as mortierella or thraustrochytrium, yeasts such as Saccharomyces or Schizosaccharomyces,
mosses such as Physcomitrella or Ceratodon, nonhuman animals such as Caenorhabditis, algae such as Nephroselmis,
Pseudoscourfielda, Prasinococcus, Scherffelia, Tetraselmis, Mantoniella, Ostreococcus, Crypthecodinium or Phaeo-
dactylum or plants such as dicotyledonous or monocotyledonous plants. Organisms which are especially advantageously
used in the process according to the invention are organisms which belong to the oil-producing organisms, that is to say
which are used for the production of oil, such as fungi, such as Mortierella or Thraustochytrium, algae such as Neph-
roselmis, Pseudoscourfielda, Prasinococcus, Scherffelia, Tetraselmis, Mantoniella, Ostreococcus, Crypthecodinium,
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Phaeodactylum, or plants, in particular plants, preferably oilseed or oil crop plants which comprise large amounts of lipid
compounds, such as peanut, oilseed rape, canola, sunflower, safflower (Carthamus tinctoria), poppy, mustard, hemp,
castor-oil plant, olive, sesame, Calendula, Punica, evening primrose, verbascum, thistle, Wild roses, hazelnut, almond,
macadamia, avocado, bay, pumpkin/squash, linseed, soybean, pistachios, borage, trees (oil palm, coconut or walnut)
or arable crops such as maize, wheat, rye, oats, triticale, rice, barley, cotton, cassava, pepper, Tagetes; Solanaceae
plants such as potato, tobacco, eggplant and tomato, Vicia species, pea, alfalfa or bushy plants (coffee, cacao, tea),
Salix species, and perennial grasses and fodder crops. Preferred plants according to the invention are oil crop plants
such as peanut, oilseed rape, canola, sunflower, safflower, poppy, mustard, hemp, castor-oil plant, olive, Calendula,
Punica, evening primrose, pumpkin/squash, linseed, soybean, borage, trees (oil palm, coconut). Especially preferred
for the process are plants which are high in C18:2-fatty acids, such as sunflower, safflower, tobacco, verbascum, sesame,
cotton, pumpkin/squash, poppy, evening primrose, walnut, linseed, hemp or thistle. Very especially preferred plants are
plants such as safflower, sunflower, poppy, evening primrose, walnut, linseed or hemp.
[0115] It is also be advantageous for the above-described method according to the invention additionally to introduce,
into the organism, further nucleic acids which encode enzymes of the fatty acid or lipid metabolism, in addition to the
nucleic acids of the first to fourth aspects of the invention.
[0116] Such nucleic acids are advantageously derived from plants such as algae, for example algae of the family of
the Prasinophyceae such as the genera Heteromastix, Mammella, Mantoniella, Micromonas, Nephroselmis, Ostreococ-
cus, Prasinocladus, Prasinococcus, Pseudoscourfielda, Pycnococcus, Pyramimonas, Scherffelia or Tetraselmis such
as the genera and species Heteromastix longifillis, Mamiella gilva, Mantoniella squamata, Micromonas pusilla, Neph-
roselmis olivacea, Nephroselmis pyriformis, Nephroselmis rotunda, Ostreococcus tauri, Ostreococcus sp. Prasinocladus
ascus, Prasinocladus lubricus, Pycnococcus provasolii, Pyramimonas amylifera, Pyramimonas disomata, Pyramimonas
obovata, Pyramimonas orientalis, Pyramimonas parkeae, Pyramimonas spinifera, Pyramimonas sp., Tetraselmis api-
culata, Tetraselmis carteriaformis, Tetraselmis chui, Tetraselmis convolutae, Tetraselmis desikacharyi, Tetraselmis gra-
cilis, Tetraselmis hazeni, Tetraselmis impellucida, Tetraselmis inconspicua, Tetraselmis levis, Tetraselmis maculata,
Tetraselmis marina, Tetraselmis striata, Tetraselmis subcordiformis, Tetraselmis suecica, Tetraselmis tetrabrachia, Tet-
raselmis tetrathele, Tetraselmis verrucosa, Tetraselmis verrucosa fo. rubens or Tetraselmis sp. or from algae of the
family Euglenaceae such as the genera Ascoglena, Astasia, Colacium, Cyclidiopsis, Euglena, Euglenopsis, Hyalophacus,
Khawkinea, Lepocinclis, Phacus, Strombomonas or Trachelomonas, such as the genera and species Euglena acus,
Euglena geniculata, Euglena gracilis, Euglena mixocylindracea, Euglena rostrifera, Euglena viridis, Colacium stentorium,
Trachelomonas cylindrica or Trachelomonas volvocina. The nucleic acids used are advantageously derived from algae
of the genera Euglena, Mantoniella or Ostreococcus.
[0117] Further advantageous plants are algae such as Isochrysis or Crypthecodinium, algae/diatoms such as Tha-
lassiosira or Phaeodactylum, mosses such as Physcomitrella or Ceratodon, or higher plants such as the Primulaceae
such as Aleuritia, Calendula stellata, Osteospermum spinescens or Osteospermum hyoseroides, microorganisms such
as fungi, such as Aspergillus, Thraustochytrium, Phytophthora, Entomophthora, Mucor or Mortierella, bacteria such as
Shewanella, yeasts or animals such as nematodes such as Caenorhabditis, insects, frogs, abalone, or fish. The isolated
nucleic acid sequences according to the invention are advantageously derived from an animal of the order of the ver-
tebrates. Preferably, the nucleic acid sequences are derived from the classes of the Vertebrata; Euteleostomi, Actinop-
terygii; Neopterygii; Teleostei; Euteleostei, Protacanthopterygii, Salmoniformes; Salmonidae or Oncorhynchus or Ver-
tebrata, Amphibia, Anura, Pipidae, Xenopus or Evertebrata such as Protochordata, Tunicata, Holothuroidea, Cionidae
such as Amaroucium constellatum, Botryllus schlosseri, Ciona intestinalis, Molgula citrina, Molgula manhattensis, Per-
ophora viridis or Styela partita. The nucleic acids are especially advantageously derived from fungi, animals, or from
plants such as algae or mosses, preferably from the order of the Salmoniformes, such as the family of the Salmonidae,
such as the genus Salmo, for example from the genera and species Oncorhynchus mykiss, Trutta trutta or Salmo trutta
fario, from algae, such as the genera Mantoniella or Ostreococcus, or from the diatoms such as the genera Thalassiosira
or Phaeodactylum or from algae such as Crypthecodinium.
[0118] In a preferred embodiment, the process furthermore comprises the step of obtaining a cell or an intact organism
which comprises the nucleic acid sequences used in the process, where the cell and/or the organism is transformed
with a nucleic acid sequence according to the invention which encodes the ∆9-elongase and optionally ∆8-desaturase
and/or the ∆5-desaturase, a gene construct or a vector as described above, alone or in combination with further nucleic
acid sequences which encode proteins of the fatty acid or lipid metabolism. In a further preferred embodiment, this
process furthermore comprises the step of obtaining the oils, lipids or free fatty acids from the organism or from the
culture. The culture can, for example, take the form of a fermentation culture, for example in the case of the cultivation
of microorganisms, such as, for example, Mortierella, Thalassiosira, Mantoniella, Ostreococcus, Saccharomyces or
Thraustochytrium, or a greenhouse- or field-grown culture of a plant. The cell or the organism produced thus is advan-
tageously a cell of an oil-producing organism, such as an oil crop, such as, for example, peanut, oilseed rape, canola,
linseed, hemp, peanut, soybean, safflower, hemp, sunflowers or borage.
[0119] In the case of plant cells, plant tissue or plant organs, "growing" is understood as meaning, for example, the
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cultivation on or in a nutrient medium, or of the intact plant on or in a substrate, for example in a hydroponic culture,
potting compost or on arable land.
[0120] For the purposes of the invention, "transgenic" or "recombinant" means with regard to, for example, a nucleic
acid sequence, an expression cassette (= gene construct) or a vector comprising the nucleic acid sequence or an
organism transformed with the nucleic acid sequences, expression cassettes or vectors according to the invention, all
those constructions brought about by recombinant methods in which either
a) the nucleic acid sequence according to the invention, or
b) a genetic control sequence which is operably linked with the nucleic acid sequence according to the invention,
for example a promoter, or
c) a) and b)
are not located in their natural genetic environment or have been modified by recombinant methods, it being possible
for the modification to take the form of, for example, a substitution, addition, deletion, inversion or insertion of one or
more nucleotide residues. The natural genetic environment is understood as meaning the natural genomic or chromo-
somal locus in the original organism or the presence in a genomic library. In the case of a genomic library, the natural
genetic environment of the nucleic acid sequence is preferably retained, at least in part. The environment flanks the
nucleic acid sequence at least on one side and has a sequence length of at least 50 bp, preferably at least 500 bp,
especially preferably at least 1000 bp, most preferably at least 5000 bp. A naturally occurring expression cassette - for
example the naturally occurring combination of the natural promoter of the nucleic acid sequences with the corresponding
∆5-desaturase gene - becomes a transgenic expression cassette when this expression cassette is modified by non-
natural, synthetic ("artificial") methods such as, for example, mutagenic treatment. Suitable methods are described, for
example, in US 5,565,350 or WO 00/15815.
[0121] A transgenic organism or transgenic plant for the purposes of the invention is therefore understood as meaning,
as above, that the nucleic acids used in the process are not at their natural locus in the genome of an organism, it being
possible for the nucleic acids to be expressed homologously or heterologously. However, as mentioned, transgenic also
means that, while the nucleic acids according to the invention are at their natural position in the genome of an organism,
the sequence has been modified with regard to the natural sequence, and/or that the regulatory sequences of the natural
sequences have been modified. Transgenic is preferably understood as meaning the expression of the nucleic acids
according to the invention at an unnatural locus in the genome, i.e. homologous or, preferably, heterologous expression
of the nucleic acids takes place. Preferred transgenic organisms are fungi such as Mortierella or Phytophtora, mosses
such as Physcomitrella, algae such as Mantoniella, Euglena, Crypthecodinium or Ostreococcus, diatoms such as Tha-
lassiosira or Phaeodactylum, or plants such as the oil crops.
[0122] Organisms or host organisms for the nucleic acids, the expression cassette or the vector used in the process
according to the invention are, in principle, advantageously all organisms which are capable of synthesizing fatty acids,
specifically unsaturated fatty acids, and/or which are suitable for the expression of recombinant genes. Examples which
may be mentioned are plants such as Arabidopsis, Asteraceae such as Calendula or crop plants such as soybean,
peanut, castor-oil plant, sunflower, maize, cotton, flax, oilseed rape, coconut, oil palm, safflower (Carthamus tinctorius)
or cacao bean, microorganisms, such as fungi, for example the genus Mortierella, Thraustochytrium, Saprolegnia,
Phytophtora or Pythium, bacteria, such as the genus Escherichia or Shewanella, yeasts, such as the genus Saccharo-
myces, cyanobacteria, ciliates, algae such as Mantoniella, Euglena, Thalassiosira or Ostreococcus, or protozoans such
as dinoflagellates, such as Crypthecodinium. Preferred organisms are those which are naturally capable of synthesizing
substantial amounts of oil, such as fungi, such as Mortierella alpina, Pythium insidiosum, Phytophtora infestans, or plants
such as soybean, oilseed rape, coconut, oil palm, safflower, flax, hemp, castor-oil plant, Calendula, peanut, cacao bean
or sunflower, or yeasts such as Saccharomyces cerevisiae with soybean, flax, oilseed rape, safflower, sunflower, Cal-
endula, Mortierella or Saccharomyces cerevisiae being especially preferred. In principle, host organisms are, in addition
to the abovementioned transgenic organisms, also transgenic animals, advantageously nonhuman animals, for example
C. elegans, Ciona intestinalis or Xenopus laevis.
[0123] Further utilizable host cells are detailed in: Goeddel, Gene Expression Technology: Methods in Enzymology
185, Academic Press, San Diego, CA (1990).
[0124] Expression strains which can be used, for example those with a lower protease activity, are described in:
Gottesman, S., Gene Expression Technology: Methods in Enzymology 185, Academic Press, San Diego, California
(1990) 119-128.
[0125] These include plant cells and certain tissues, organs and parts of plants in all their phenotypic forms such as
anthers, fibers, root hairs, stalks, embryos, calli, cotelydons, petioles, harvested material, plant tissue, reproductive
tissue and cell cultures which are derived from the actual transgenic plant and/or can be used for bringing about the
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transgenic plant.
[0126] Transgenic plants which comprise the polyunsaturated fatty acids synthesized in the process according to the
invention can advantageously be marketed directly without there being any need for the oils, lipids or fatty acids syn-
thesized to be isolated. Plants for the process according to the invention are listed as meaning intact plants and all plant
parts, plant organs or plant parts such as leaf, stem, seeds, root, tubers, anthers, fibers, root hairs, stalks, embryos,
calli, cotelydons, petioles, harvested material, plant tissue, reproductive tissue and cell cultures which are derived from
the actual transgenic plant and/or can be used for bringing about the transgenic plant. In this context, the seed comprises
all parts of the seed such as the seed coats, epidermal cells, seed cells, endosperm or embryonic tissue. However, the
compounds produced in the process according to the invention can also be isolated from the organisms, advantageously
plants, in the form of their oils, fats, lipids and/or free fatty acids. Polyunsaturated fatty acids produced by this process
can be obtained by harvesting the organisms, either from the crop in which they grow, or from the field. This can be
done via pressing or extraction of the plant parts, preferably the plant seeds. In this context, the oils, fats, lipids and/or
free fatty acids can be obtained by what is known as cold-beating or cold-pressing without applying heat. To allow for
greater ease of disruption of the plant parts, specifically the seeds, they are previously comminuted, steamed or roasted.
The seeds which have been pretreated in this manner can subsequently be pressed or extracted with solvents such as
warm hexane. The solvent is subsequently removed. In the case of microorganisms, the latter are, after harvesting, for
example extracted directly without further processing steps or else, after disruption, extracted via various methods with
which the skilled worker is familiar. In this manner, more than 96% of the compounds produced in the process can be
isolated. Thereafter, the resulting products are processed further, i.e. refined. In this process, substances such as the
plant mucilages and suspended matter are first removed. What is known as desliming can be effected enzymatically or,
for example, chemico-physically by addition of acid such as phosphoric acid. Thereafter, the free fatty acids are removed
by treatment with a base, for example sodium hydroxide solution. The resulting product is washed thoroughly with water
to remove the alkali remaining in the product and then dried. To remove the pigment remaining in the product, the
products are subjected to bleaching, for example using filler’s earth or active charcoal. At the end, the product is deo-
dorized, for example using steam.
[0127] The fatty acids produced by the processes of the present invention can be isolated from the organism in the
form of an oil, a lipid or a free fatty acid. Suitable organisms are, for example, those mentioned above. Preferred organisms
are transgenic plants.
[0128] There is described oils, lipids or fatty acids of formula 1 or fractions thereof which have been produced by the
above-described process, especially preferably oil, lipid or a fatty acid composition comprising a compound of formula
I and being derived from transgenic plants.
[0129] There is also described the use of the oil, lipid, the fatty acids and/or the fatty acid composition in feedstuffs,
foodstuffs, cosmetics or pharmaceuticals. The oils, lipids, fatty acids or fatty acid mixtures according to the invention
can be used in the manner with which the skilled worker is familiar for mixing with other oils, lipids, fatty acids or fatty
acid mixtures of animal origin, such as, for example, fish oils. These oils, lipids, fatty acids or fatty acid mixtures, which
are composed of vegetable and animal constituents, may also be used for the preparation of feedstuffs, foodstuffs,
cosmetics or pharmacologicals.
[0130] The term "oil", "lipid" or "fat" is understood as meaning a fatty acid mixture comprising unsaturated, saturated,
preferably esterified, fatty acid(s). The oil, lipid or fat is preferably high in polyunsaturated free or, advantageously,
esterified fatty acid(s), in particular linoleic acid, γ-linolenic acid, dihomo-γ-linolenic acid, arachidonic acid, α-linolenic
acid, stearidonic acid, eicosatetraenoic acid, eicosapentaenoic acid, docosapentaenoic acid or docosahexaenoic acid.
[0131] The amount of unsaturated esterified fatty acids preferably amounts to approximately 30%, a content of 50%
is more preferred, a content of 60%, 70%, 80% or more is even more preferred. For the analysis, the fatty acid content
can, for example, be determined by gas chromatography after converting the fatty acids into the methyl esters by
transesterification. The oil, lipid or fat can comprise various other saturated or unsaturated fatty acids, for example
calendulic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid and the like. The content of the various fatty acids
in the oil or fat can vary, in particular depending on the starting organism.
[0132] The ARA produced in the process may be, as described above, in the form of fatty acid derivatives, for example
sphingolipids, phosphoglycerides, lipids, glycolipids, phospholipids, monoacylglycerol, diacylglycerol, triacylglycerol or
other fatty acid esters.
[0133] The ARA and other polyunsaturated fatty acids which are present can be liberated for example via treatment
with alkali, for example aqueous KOH or NaOH, or acid hydrolysis, advantageously in the presence of an alcohol such
as methanol or ethanol, or via enzymatic cleavage, and isolated via, for example, phase separation and subsequent
acidification via, for example, H2SO4. The fatty acids can also be liberated directly without the above-described processing
step.
[0134] After their introduction into an organism, advantageously a plant cell or plant, the nucleic acids used in the
process can either be present on a separate plasmid or, advantageously, integrated into the genome of the host cell. In
the case of integration into the genome, integration can be random or else be effected by recombination such that the
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native gene is replaced by the copy introduced, whereby the production of the desired compound by the cell is modulated,
or by the use of a gene in trans, so that the gene is linked operably with a functional expression unit which comprises
at least one sequence which ensures the expression of a gene and at least one sequence which ensures the polyade-
nylation of a functionally transcribed gene. The nucleic acids are advantageously introduced into the organisms via
multiexpression cassettes or constructs for multiparallel expression, advantageously into the plants for the multiparallel
seed-specific expression of genes.
[0135] If microorganisms such as yeasts, such as Saccharomyces or Schizosaccharomyces, fungi such as Mortierella,
Aspergillus, Phytophtora, Entomophthora, Mucor or Thraustochytrium, algae such as Isochrysis, Mantoniella, Euglena,
Ostreococcus, Phaeodactylum or Crypthecodinium are used as organisms in the process according to the invention,
these organisms are advantageously grown in fermentation cultures.
[0136] If microorganisms are used as organisms in the process according to the invention, they are grown or cultured
in the manner with which the skilled worker is familiar, depending on the host organism. As a rule, microorganisms are
grown in a liquid medium comprising a carbon source, usually in the form of sugars, a nitrogen source, usually in the
form of organic nitrogen sources such as yeast extract or salts such as ammonium sulfate, trace elements such as salts
of iron, manganese and magnesium and, if appropriate, vitamins, at temperatures of between 0°C and 100°C, preferably
between 10°C and 60°C, while passing in oxygen. The pH of the liquid medium can either be kept constant, that is to
say regulated during the culturing period, or not. The cultures can be grown batchwise, semi-batchwise or continuously.
Nutrients can be provided at the beginning of the fermentation or fed in semicontinuously or continuously. The polyun-
saturated fatty acids produced can be isolated from the organisms as described above by processes known to the skilled
worker, for example by extraction, distillation, crystallization, if appropriate precipitation with salt, and/or chromatography.
To this end, the organisms can advantageously be disrupted beforehand.
[0137] If the host organisms are microorganisms, the process according to the invention is advantageously carried
out at a temperature of between 0°C and 95°C, preferably between 10°C and 85°C, especially preferably between 15°C
and 75°C, very especially preferably between 15°C and 45°C.
[0138] In this process, the pH value is advantageously kept between pH 4 and 12, preferably between pH 6 and 9,
especially preferably between pH 7 and 8.
[0139] The process according to the invention can be operated batchwise, semibatchwise or continuously. An overview
over known cultivation methods can be found in the textbook by Chmiel (Bioprozeßtechnik 1. Einführung in die Biover-
fahrenstechnik [Bioprocess technology 1. Introduction to Bioprocess technology] (Gustav Fischer Verlag, Stuttgart,
1991)) or in the textbook by Storhas (Bioreaktoren und periphere Einrichtungen [Bioreactors and peripheral equipment]
(Vieweg Verlag, Braunschweig/Wiesbaden, 1994)).
[0140] The culture medium to be used must suitably meet the requirements of the strains in question. Descriptions of
culture media for various microorganisms can be found in the textbook "Manual of Methods für General Bacteriology"
of the American Society for Bacteriology (Washington D. C., USA, 1981).
[0141] As described above, these media which can be employed in accordance with the invention usually comprise
one or more carbon sources, nitrogen sources, inorganic salts, vitamins and/or trace elements.
[0142] Preferred carbon sources are sugars, such as mono-, di- or polysaccharides. Examples of very good carbon
sources are glucose, fructose, mannose, galactose, ribose, sorbose, ribulose, lactose, maltose, sucrose, raffinose, starch
or cellulose. Sugars can also be added to the media via complex compounds such as molasses or other byproducts
from sugar raffination. The addition of mixtures of a variety of carbon sources may also be advantageous. Other possible
carbon sources are oils and fats such as, for example, soya oil, sunflower oil, peanut oil and/or coconut fat, fatty acids
such as, for example, palmitic acid, stearic acid and/or linoleic acid, alcohols and/or polyalcohols such as, for example,
glycerol, methanol and/or ethanol, and/or organic acids such as, for example, acetic acid and/or lactic acid.
[0143] Nitrogen sources are usually organic or inorganic nitrogen compounds or materials comprising these com-
pounds. Examples of nitrogen sources comprise ammonia in liquid or gaseous form or ammonium salts such as am-
monium sulfate, ammonium chloride, ammonium phosphate, ammonium carbonate or ammonium nitrate, nitrates, urea,
amino acids or complex nitrogen sources such as cornsteep liquor, soya meal, soya protein, yeast extract, meat extract
and others. The nitrogen sources can be used individually or as a mixture.
[0144] Inorganic salt compounds which may be present in the media comprise the chloride, phosphorus and sulfate
salts of calcium, magnesium, sodium, cobalt, molybdenum, potassium, manganese, zinc, copper and iron.
[0145] Inorganic sulfur-containing compounds such as, for example, sulfates, sulfites, dithionites, tetrathionates, thi-
osulfates, sulfides, or else organic sulfur compounds such as mercaptans and thiols may be used as sources of sulfur
for the production of sulfur-containing fine chemicals, in particular of methionine.
[0146] Phosphoric acid, potassium dihydrogen phosphate or dipotassium hydrogen phosphate or the corresponding
sodium-containing salts may be used as sources of phosphorus.
[0147] Chelating agents may be added to the medium in order to keep the metal ions in solution. Particularly suitable
chelating agents include dihydroxyphenols such as catechol or protocatechuate and organic acids such as citric acid.
[0148] The fermentation media used according to the invention for culturing microorganisms usually also comprise
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other growth factors such as vitamins or growth promoters, which include, for example, biotin, riboflavin, thiamine, folic
acid, nicotinic acid, panthothenate and pyridoxine. Growth factors and salts are frequently derived from complex media
components such as yeast extract, molasses, cornsteep liquor and the like. It is moreover possible to add suitable
precursors to the culture medium. The exact composition of the media compounds heavily depends on the particular
experiment and is decided upon individually for each specific case. Information on the optimization of media can be
found in the textbook "Applied Microbiol. Physiology, A Practical Approach" (Editors P.M. Rhodes, P.F. Stanbury, IRL
Press (1997) pp. 53-73, ISBN 0 19 963577 3). Growth media can also be obtained from commercial suppliers, for
example Standard 1 (Merck) or BHI (brain heart infusion, DIFCO) and the like.
[0149] All media components are sterilized, either by heat (20 min at 1.5 bar and 121°C) or by filter sterilization. The
components may be sterilized either together or, if required, separately. All media components may be present at the
start of the cultivation or added continuously or batchwise, as desired.
[0150] The culture temperature is normally between 15°C and 45°C, preferably at from 25°C to 40°C, and may be
kept constant or may be altered during the experiment. The pH of the medium should be in the range from 5 to 8.5,
preferably around 7.0. The pH for cultivation can be controlled during cultivation by adding basic compounds such as
sodium hydroxide, potassium hydroxide, ammonia and aqueous ammonia or acidic compounds such as phosphoric
acid or sulfuric acid. Foaming can be controlled by employing antifoams such as, for example, fatty acid polyglycol
esters. To maintain the stability of plasmids it is possible to add to the medium suitable substances having a selective
effect, for example antibiotics. Aerobic conditions are maintained by introducing oxygen or oxygen-containing gas mix-
tures such as, for example, ambient air into the culture. The temperature of the culture is normally 20° to 40°C and
preferably 25°C to 40°C. The culture is continued until formation of the desired product is at a maximum. This aim is
normally achieved within 10 to 160 hours.
[0151] The fermentation broths obtained in this way, in particular those containing polyunsaturated fatty acids, usually
contain a dry mass of from 7.5 to 25% by weight.
[0152] The fermentation broth can then be processed further. The biomass may, according to requirement, be removed
completely or partially from the fermentation broth by separation methods such as, for example, centrifugation, filtration,
decanting or a combination of these methods or be left completely in said broth. It is advantageous to process the
biomass after its separation.
[0153] However, the fermentation broth can also be thickened or concentrated without separating the cells, using
known methods such as, for example, with the aid of a rotary evaporator, thin-film evaporator, falling-film evaporator,
by reverse osmosis or by nanofiltration. Finally, this concentrated fermentation broth can be processed to obtain the
fatty acids present therein.
[0154] The fatty acids obtained in the process are also suitable as starting material for the chemical synthesis of further
products of interest. For example, they can be used in combination with one another or alone for the preparation of
pharmaceuticals, foodstuffs, animal feeds or cosmetics.
[0155] All of the nucleic acid sequences used in the process according to the invention are advantageously derived
from a eukaryotic organism such as a plant, a microorganism or an animal. The nucleic acid sequences are preferably
derived from the order Salmoniformes, algae such as Mantoniella, Crypthecodinium, Euglena or Ostreococcus, fungi
such as the genus Phytophthora or from diatoms such as the genera Thalassiosira or Phaeodactylum.
[0156] The invention will now be described in greater detail with reference to the following Examples and to the
drawings in which:
FIGURE 1 shows various synthetic pathways for the biosynthesis of ω-6 and ω-3 fatty acids.
FIGURE 2 is a gas chromatography trace showing the conversion of ∆9,12-18:2 (linoleic acid) to ∆11,14-20:2 by
heterologous expression of the P. marinus ∆9-elongase sequence (SEQ ID NO: 1, residues 7668 to 9200) in yeast
induced either by galactose (Figure 2A) or glucose (Figure 2B).
Example 1 - Cloning of a FAE1 elongase from Perkinsus marinus
[0157] Perkinsus marinusi is an oyster protozoan parasite capable of synthesizing saturated and unsaturated fatty
acids including the essential fatty acid, arachidonic acid [20:4(n-6)]. P. marinus employs the delta-8 (∆-8) desaturase
pathway to synthesize arachidonic acid.
Materials and Methods.
Growth and harvesting of P. marinus.
[0158] Perkinsus marinus meronts were cultivated at 28°C in a medium prepared as described by La Peyre et al. (J
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Eukaryot Microbiol 1993;40:304-10) and contained amino acids, nucleotides, carbohydrates, and vitamins, but no fetal
bovine serum.
Nucleic acid manipulation and PCR-based cloning.
[0159] DNA was extracted from cells using a DNeasy DNA mini kit (Qiagen). DNA were amplified with primers specific
to delta5 desaturase gene as follows: the reactions were heated to 95 C for 2 min followed by 35 cycles at 95 C for 1
min, 2 min at 52 and 72 C for 4 min, then a single step at 72 C for 5 min. PCR amplification products were cloned into
TOPO vector (Invitrogen) and verified by sequencing. FAE elongase gen was amplified with gene-specific primers
(TableI) designed to the 5’ and 3’ ends of the coding region, with restriction sites to facilitate cloning into the yeast vector
(Table I). Forward primers for cloning into yeast expression vector pYES2 (Invitrogen) were designed to contain a G/A
at position -3 and a G at position +4 to improve translation initiation in eukaryotic cells.
Oligonucleotide primers used in this study.
[0160] Transcripts of Perkinsus marinus were analyzed by reverse transcriptase PCR (RT-PCR). Total RNA was
extracted from cells using an RNeasy plant mini kit (Qiagen). First strand cDNA was synthesised from total RNA using
the SMART RACE cDNA Amplification kit (BD-Clontech, Basingstoke, UK) according to the manufacture’s instructions.
Single -stranded cDNAs were amplified with following primers.
FAEoperon reverse 5’-CATCTGCGAATACTAACCATACATT
[0161] The reactions were heated to 95 C for 2 min followed by 30 cycles at 94 C for 30 s, 30 s at temperatures ranging
from 55 to 72 according to the primer design and 72 C for 2 min, then a single step at 72 C for 10 min. PCR amplification
products were cloned into TOPO vector (Invitrogen) and verified by sequencing. Surprisingly it was shown that the
transcripts of the ∆9-elongase, ∆8-desaturase and ∆5-desaturase are all found on the the same mRNA. This is the first
example showing PUFA genes to be organized in an operon-like structure.
[0162] In a further investigation the specificity of the ∆9-elongase was analyzed. For this purpose the coding sequence
of this gene was amplified by RT-PCR as described above using following primers.
Elo2For: 5’- ATGCAAGTTCCCGCGGAGCATCACTCC -3’
Elo2Rev: 5’- CGTTACGCATCAATATTATGCATAGCCAACC -3’
[0163] The amplified PCR product was then cloned into a pCRscript vector according to manufacture’s recommen-
dations (Stratagen). In a second PCR step the modified sequences for yeast expression were introduced using following
primers.
Yeast expression.
[0164] Kpn Elo2For 5’- TTGGTACCATGGGATTTCCTGCGGAG -3’
Sac Elo1 Rev 5’- GGGAGCTCTTACGCATCAATATTATGCATAGC-3’
[0165] Sequence of the primers is given in the 5’ to 3’ orientation
Restriction sites used for cloning are in bold.
RESULTS
Isolation of FAE1 elongase from P.marinus.
[0166] Using publicly available data derived from an P.marinus genome sequencing project carried out by TIGR (http:
//www.tigr.org/tdb/e2k1/pmg/) we identified one contig (1047306867) which showed significant homology to known elon-
gases, with the target sequence (designated Elo1 For, SEQ ID NO: 9) consisting of an open reading frame of 511
residues and no introns. The putative amino acid derived from the target sequence is SEQ ID NO: 10.
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Functional characterisation in Saccharomyces cerevisiae.
[0167] The full-length cDNA corresponding to putative ∆9 fatty acid elongase (SEQ ID NO: 9) was cloned into yeast
expression vector pYES2 to give a construct designated pYPmFAE. S.cerevisiae strain W303-1A was transformed with
the pYPmFAE or the empty vector as a control. Transformed cell were grown in a minimal medium containing raffinose
and induced with 2% galactose. After 48h of growth total yeast fatty acids were extracted and the resulting FAMEs
analysed by GC.
[0168] GC analysis (Figure 2) revealed that yeast cells transformed with pYPmFAE produced an additional fatty acid,
which was identified as eicosadienoic acid indicating that the gene we had cloned encoded a delta 9 fatty acid elongase.
Yeast cells expressing the P. marinus delta 9 fatty acid elongase is capable of recognizing C18:2 (c9,12) substrate with
a 8.2% percentage of conversion rate.
[0169] Table 1 shows the fatty acid content of the yeast cells after transformation with pYPmFAE (+) or with the empty
vector pYES2 (-) and induction with 2% galactose. The percentage conversion for 18:2∆9,12 to 20:2∆11,14, for example
is calculated by the equation: 
E
P
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TABLE 1
FATTY ACIDS
% 16:0 16:1∆9 18:0 18:1∆9 18:2∆9,12 20:2∆11,14 18:3∆6,9,12 20:3∆8,11,14 20:4∆5,8,11,14 22:4∆7,10,13,16 % conv
FAE 18:2+ 19.05 22.79 5.15 12.54 37.14 3.33 0.00 0.00 0.00 0.00 8.2
FAE 18:2- 20.81 19.50 5.50 12.11 42.07 0.00 0.00 0.00 0.00 0.00 0.0
FAE 18:3+ 18.86 19.77 4.81 11.15 0.00 0.00 44.93 0.48 0.00 0.00 1.1
FAE 18:3- 20.35 18.15 4.84 10.33 0.00 0.00 46.27 0.07 0.00 0.00 0.1
FAE 20:4+ 20.84 31.09 5.48 15.91 0.00 0.00 0.00 0.00 26.68 0.00 0.0
FAE 20:4- 22.13 31.00 4.55 14.65 0.00 0.00 0.00 0.00 27.67 0.00 0.0
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[0170] The results presented in Table 1 show that no elongase activity was detected with 20:4∆5,8,11,14, and a minimal
activity (1% conversion) for 18:3∆6,9,12. It therefore appears that the ∆9 fatty acid elongase is selective for linoleic acid
and does not act to elongate other PUFAs.
SEQUENCE LISTING
[0171]
<110> BASF
<120> Nucleic Acid
<130> DY-03
<160> 10
<170> PatentIn version 3.1
<210> 1
<211> 18342
<212> DNA
<213> Perkinsus marinus
<220>
<221> CDS
<222> (7668)..(9200)
<223>
<220>
<221> CDS
<222> (9351)..(10724)
<223>
<220>
<221> CDS
<222> (10842)..(12077)
<223>
<400> 1
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<210> 2
<211> 510
<212> PRT
<213> Perkinsus marinus
<400> 2
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<210> 3
<211> 457
<212> PRT
<213> Perkinsus marinus
<400> 3
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<210> 4
<211> 411
<212> PRT
<213> Perkinsus marinus
<400> 4
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<210> 5
<211> 27
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer sequence
<400> 5
<210> 6
<211> 31
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer sequence
<400> 6
<210> 7
<211> 26
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer sequence with restriction sites for cloning into yeast expression vector
<400> 7
<210> 8
<211> 32
<212> DNA
<213> Artificial Sequence
<220>
<223> Primer sequence
<400> 8
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<210> 9
<211> 1533
<212> DNA
<213> Perkinsus marinus
<220>
<221> CDS
<222> (1)..(1533)
<223>
<400> 9
EP 1 984 502 B1
57
5
10
15
20
25
30
35
40
45
50
55
EP 1 984 502 B1
58
5
10
15
20
25
30
35
40
45
50
55
EP 1 984 502 B1
59
5
10
15
20
25
30
35
40
45
50
55
<210> 10
<211> 510
<212> PRT
<213> Artificial Sequence
<220>
<400> 10
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Claims
1. An isolated nucleic acid molecule which encodes a polypeptide with ∆9-elongase activity and which is selected from
the group consisting of:
a) a sequence comprising nucleic acid residues 7668 to 9200 of SEQ ID NO: 1;
b) an isolated nucleic acid sequence which encodes a polypeptide with ∆9-elongase activity, wherein the polypep-
tide comprises SEQ ID NO: 2;
c) a derivative of a sequence comprising nucleic acid residues 7668 to 9200 of SEQ ID NO: 1 which encodes
a polypeptide with at least 85% identity at the amino acid level with SEQ ID NO: 2 over the entire length of SEQ
ID NO: 2; wherein said polypeptide has ∆9-elongase activity.
2. A polypeptide with ∆9-elongase activity which is encoded by a nucleic acid molecule as claimed in claim 1.
3. A gene construct comprising a nucleic acid molecule as claimed in claim 1 operably linked with one or more regulatory
sequences.
4. A vector comprising a nucleic acid molecule as claimed in claim 1 or a gene construct as claimed in a claim 3.
5. A transgenic non-human organism comprising at least one transgene comprising a nucleic acid molecule according
to claim 1, a gene construct according to claim 3 or a vector according to claim 4.
6. A transgenic non-human organism as claimed in claim 5, which organism is a microorganism, a non-human animal
or a plant.
7. A transgenic non-human organism according to claim 6, which organism is a plant.
8. A process for the conversion of 18:2∆9,12 (linoleic acid) to 20:2∆11,14, the process comprising introducing into an
organism which comprises linoleic acid at least one nucleic acid molecule which encodes a polypeptide having ∆9-
elongase activity and which comprises :
a) a sequence comprising nucleic acid residues 7668 to 9200 of SEQ ID NO: 1;
b) an isolated nucleic acid sequence which encodes a polypeptide with ∆9-elongase activity, wherein the polypep-
tide comprises SEQ ID NO: 2;
c) a derivative of a sequence comprising nucleic acid residues 7668 to 9200 of SEQ ID NO: 1 which encodes
a polypeptide with at least 85% identity at the amino acid level with SEQ ID NO: 2 over the entire length of SEQ
ID NO:2, wherein said polypeptide has ∆9-elongase activity;
and expressing said nucleic acid sequence.
9. A process as claimed in claim 8, further including the step of induction with galactose.
10. A process as claimed in claim 8 or 9, wherein the organism is a microorganism, a non-human animal or a plant.
Patentansprüche
1. Isoliertes Nukleinsäuremolekül, welches ein Polypeptid mit ∆9-Elongaseaktivität kodiert, und welches ausgewählt
aus der Gruppe, bestehend aus:
a) eine Sequenz, umfassend die Nukleinsäurereste 7668 bis 9200 von SEQ ID Nr. 1,
b) eine isolierte Nukleinsäuresequenz, welche ein Polypeptid mit ∆9-Elongaseaktvität kodiert, wobei das Poly-
peptid SEQ ID Nr. 2 umfasst,
c) ein Derivat einer Sequenz, umfassend die Nukleinsäurereste 7668 bis 9200 von SEQ ID Nr. 1, welche ein
Polypeptid mit wenigstens 85 % Identität auf der Aminosäureebene mit SEQ ID Nr. 2 über die gesamte Länge
von SEQ ID Nr. 2 kodiert, wobei das Polypeptid ∆9-Elongaseaktivität aufweist.
2. Polypeptid mit ∆9-Elongaseaktivität, welches von einem Nukleinsäuremolekül, wie es in Anspruch 1 beansprucht
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wird, kodiert wird.
3. Genkonstrukt, umfassend ein Nukleinsäuremolekül, wie es in Anspruch 1 beansprucht wird, welches mit einer oder
mehreren regulierenden Sequenzen funktionsfähig verknüpft ist.
4. Vektor, umfassend ein Nukleinsäuremolekül, wie es in Anspruch 1 beanspruch wird, oder ein Genkonstrukt, wie es
in Anspruch 3 beansprucht wird.
5. Transgener nicht-menschlicher Organismus, umfassend wenigstens ein Transgen, welches ein Nukleinsäuremo-
lekül nach Anspruch 1, ein Genkonstrukt nach Anspruch 3 oder einen Vektor nach Anspruch 4 umfasst.
6. Transgener nicht-menschlicher Organismus, wie er in Anspruch 5 beansprucht wird, welcher Organismus ein Mir-
koorganismus, ein nicht-menschliches Tier oder eine Pflanze ist.
7. Transgener nicht-menschlicher Organismus nach Anspruch 6, welcher Organismus eine Pflanze ist.
8. Verfahren für die Umwandlung von 18:2∆9,12 (Linolsäure) in 20:2∆1,14, wobei das Verfahren umfasst, dass man in
einen Organismus, welcher Linolsäure enthält, wenigstens ein Nukleinsäuremolekül einbringt, welches ein Poly-
peptid mit ∆9-Elongaseaktivität kodiert und welches umfasst:
a) eine Sequenz, umfassend die Nukleinsäurereste 7668 bis 9200 von SEQ ID Nr. 1,
b) eine isolierte Nukleinsäuresequenz, welche ein Polypeptid mit ∆9-Elongaseaktivität kodiert, wobei das Po-
lypeptid SEQ ID Nr. 2 umfasst,
c) ein Derivat einer Sequenz, umfassend die Nukleinsäurereste 7668 bis 9200 von SEQ ID Nr. 1, welche ein
Polypeptid mit wenigstens 85 % Identität auf der Aminosäureebene mit SEQ ID Nr. 2 über die gesamte Länge
von SEQ ID Nr. 2 kodiert, wobei das Polypeptid ∆9-Elongaseaktivität aufweist,
und die Nukleinsäuresequenz exprimiert.
9. Verfahren nach Anspruch 8, welches weiterhin die Stufe der Induktion mit Galaktose einschließt.
10. Verfahren nach Anspruch 8 oder 9, wobei der Organismus ein Mikroorganismus, ein nicht-menschliches Tier oder
eine Pflanze ist.
Revendications
1. Molécule d’acide nucléique isolée qui code un polypeptide à activité ∆9-élongase et qui est choisie dans le groupe
consistant en :
a) une séquence comprenant les résidus d’acide nucléique 7668 à 9200 de SEQ ID NO : 1 ;
b) une séquence d’acide nucléique isolée qui code un polypeptide à activité ∆9-élongase, où le polypeptide
comprend SEQ ID NO : 2 ;
c) un dérivé d’une séquence comprenant les résidus d’acide nucléique 7668 à 9200 de SEQ ID NO : 1 qui code
un polypeptide ayant au moins 85 % d’identité au niveau des aminoacides avec SEQ ID NO : 2 sur toute la
longueur de SEQ ID NO : 2 ; où ledit polypeptide a une activité ∆9-élongase.
2. Polypeptide à activité ∆9-élongase qui est codé par une molécule d’acide nucléique selon la revendication 1.
3. Construction génique comprenant une molécule d’acide nucléique selon la revendication 1 liée de manière fonc-
tionnelle à une ou plusieurs séquences régulatrices.
4. Vecteur comprenant une molécule d’acide nucléique selon la revendication 1 ou une construction génique selon la
revendication 3.
5. Organisme transgénique non humain comprenant au moins un transgène comprenant une molécule d’acide nu-
cléique selon la revendication 1, une construction génique selon la revendication 3 ou un vecteur selon la revendi-
cation 4.
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6. Organisme transgénique non humain selon la revendication 5, lequel organisme est un micro-organisme, un animal
non humain ou une plante.
7. Organisme transgénique non humain selon la revendication 6, lequel organisme est une plante.
8. Procédé pour la conversion de 18:2∆9,12 (acide linoléique) en 20:2∆11,14, le procédé comprenant l’introduction dans
un organisme qui comprend de l’acide linoléique d’au moins une molécule d’acide nucléique qui code un polypeptide
ayant une activité ∆9-élongase et qui comprend :
a) une séquence comprenant les résidus d’acide nucléique 7668 à 9200 de SEQ ID NO : 1 ;
b) une séquence d’acide nucléique isolée qui code un polypeptide à activité ∆9-élongase, où le polypeptide
comprend SEQ ID NO : 2 ;
c) un dérivé d’une séquence comprenant les résidus d’acide nucléique 7668 à 9200 de SEQ ID NO : 1 qui code
un polypeptide ayant au moins 85 % d’identité au niveau des aminoacides avec SEQ ID NO : 2 sur toute la
longueur de SEQ ID NO : 2 ; où ledit polypeptide a une activité ∆9-élongase ;
et l’expression de ladite séquence d’acide nucléique.
9. Procédé selon la revendication 8 incluant en outre l’étape d’induction avec le galactose.
10. Procédé selon la revendication 8 ou 9 où l’organisme est un micro-organisme, un animal non humain ou une plante.
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